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ACC MEMBERS SHOW HIGH LEVEL OF SATISFACTION.
American College of Cardiology (ACC) members remain
satisﬁed with the organization and its goals of trans-
forming cardiovascular care and helping members
thrive in any delivery or reimbursement environment.
They are likely to recommend the College to others
because of the perceived value of beneﬁts such as the
Journal of the American College of Cardiology (JACC)journals, educational resources, and clinical guidelines.
Reimbursement, work-life balance, certiﬁcation issues,
keeping up to date clinically, and rising costs top the list
of member challenges.
SHIFT TOWARD VALUE-BASED PAYMENT CONTINUES.
The federal government accelerated its shift away
from fee-for-service and toward value-based pay-
ment, setting a goal of 30% of Medicare payments
from value-based models by 2016 and 50% by 2018.ealth Science Center at Houston, Houston, Texas;
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D2Medicare payment structures are being modiﬁed over
time to include more rewards based on performance,
increasing both the risks and potential rewards for
healthcare providers. The Medicare Sustainable
Growth Rate (SGR) formula was ﬁnally repealed by
Congress and a policy favoring value-based payments
over quantity-based payments enacted. ACC members
view this shift as a major practice focus, and many are
participating in value-based pilot programs.
PROPOSED CHANGES IN CERTIFICATION LEAD TO
CONTROVERSY. A decision by the American Board
of Internal Medicine (ABIM) to stiffen its Maintenance
of Certiﬁcation (MOC) program led to signiﬁcant resis-
tance from physicians who found the new requirements
to be burdensome, irrelevant to practice, and of ques-
tionablevalue in improving thequalityof care.Thedebate
spilled from professional journals into the consumer
press, while the ACC and other medical professional
organizations encouraged modiﬁcations of the new
requirements. Early in 2015, the ABIM acknowledged its
miscalculations, announced signiﬁcant changes to the
MOC program, and indicated a willingness to work more
closely with the internal medicine community.
AFFORDABLE CARE ACTHITS FIFTH-YEARANNIVERSARY,
SURVIVES MAJOR CHALLENGE. The Affordable Care
Act (ACA) marked its ﬁfth anniversary in 2015,
providing health insurance to millions and driving a
historic reduction in the percentage of uninsured
Americans. Opinion polls showed favorable opinions
of the ACA topping unfavorable opinions of the new
law for the ﬁrst time. A Centers for Medicare and
Medicaid Services (CMS) report on the impact of the
ACA showed increases in patient safety, reductions in
hospital readmission, and new sources of consumer
information about the quality of care. A mid-year
ruling by the U.S. Supreme Court upheld a key part
of the ACA that provides health insurance subsidies
for all qualifying Americans.
CARDIOVASCULAR DISEASE COST REMAINS HIGH,
CARDIOLOGY REIMBURSEMENT DECLINES. Cardio-
vascular disease (CVD) remains the nation’s single
most costly diagnostic group, with a cost expected to
top $1 trillion by 2030. However, after years of steady
increases, compensation for cardiologists declined.
The repeal of the SGR formula will bring small pay-
ment increases over the next 5 years, after which new
value-based payment formulas will begin. The ACC
and the American Heart Association (AHA) have
begun to build value assessments as well as clinical
efﬁcacy into clinical documents. National investment
in CVD research remains at relatively low levels.
SUPPLY AND DEMAND FOR HEALTHCARE WORKERS
BECOMING LESS PREDICTABLE. The World HealthOrganization (WHO) predicts signiﬁcant future global
shortages of healthcare workers, but the possibility of
healthcare worker shortages in the United States is harder
to predict. There will be some increases in the supply of
healthcare workers in this country, and some predict
future demand to exceed that supply. In cardiology,
however, recent rapid changes in the practice landscape
maymean that supply and demandmay vary signiﬁcantly
by subspecialty and by geographic location. Cardiology
groups have reported decreases in utilization for many of
the historically high-volume diagnostic tests and cardiac
procedures. Surveys of hospitals and health systems show
the emergence of new types of healthcare workers such as
care coordinators.
TEAM-BASED CARE GAINS TRACTION. A move to
team-based care is being driven by the increased
complexity of medicine as well as regulatory and
market factors. While in general, team-based care
draws much support in the medical community, there
are differing views about the level of independence
for nonphysician clinicians and the need for physi-
cian supervision. Scope of practice for healthcare
professionals varies by state. In cardiology, the ACC is
pioneering the evolution of team-based care, and in
2015, the ACC issued a new policy statement that
promotes ﬂexibility regarding team leadership and
focuses on shared goals and clear roles for the team.
BURDEN OF CVD REMAINS HIGH. There has been a
signiﬁcant decline in mortality rates for CVD since
1960, yet it remains the overall leading cause of death
in the United States. There has been an increased focus
in this country on healthy behaviors such as diet,
physical activity, and not smoking and health factors
such as control of blood pressure, blood sugar, and
blood cholesterol. CVD is also the leading cause of
death globally, and under the leadership of the WHO,
all member states agreed in 2013 to reduce the number
of premature deaths by noncommunicable diseases by
25% by 2025. Aging and population growth are causing
an increase in global CVD deaths despite a decrease in
age-speciﬁc death rates in most regions.
U.S. HEALTHCARE SYSTEM CONTINUES TO UNDER-
PERFORM. The United States continues to have
the world’s most expensive healthcare system while
underperforming on some indices of quality compared
with other industrialized countries. The rate of
healthcare spending is expected to increase after
a 5-year slowdown. Drivers of increased spending
include administrative complexity, the increasing
burden of chronic disease, and the use of technologi-
cally advanced equipment and procedures. Signiﬁcant
drivers of change in the system include consolidation,
information technology, and consumerism.
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D3INFORMATION TECHNOLOGY RAPIDLY BEING
ADOPTED, BUT HURDLES REMAIN. The adoption of
information technology has grown rapidly, but much
progress remains to be made in interoperability and
information sharing. The availability of technical
assistance, the use of ﬁnancial incentives, board cer-
tiﬁcation requirements, and the ability to exchange
patient information are the top drivers of physician
adoption of information technology. Barriers to
interoperability include insufﬁcient infrastructure,
competition between information vendors, technol-
ogy challenges, and unresolved policy issues. There is
increasing frustration with the complexity of gov-
ernment ﬁnancial incentive programs.
SIGNIFICANT CHANGES TAKING PLACE IN CLINICAL
RISK ASSESSMENT AND CHOLESTEROL MANAGEMENT.
New guidelines on the assessment of cardiovas-
cular risk and the treatment of blood cholesterol have
been released, along with a new online risk calculator.
These new clinical tools have introduced broader
assessment and prevention strategies, set a founda-
tion for future value-based payment strategies, and
stirred controversy. These signiﬁcant departures from
previous approaches generated controversy, but sub-
sequent studies seem to provide support for the new
approaches. The ﬁrst drugs in a new class of
cholesterol-loweringmedications have been approved
and are highly effective in reducing low-density lipo-
protein (LDL) cholesterol but are extremely costly,
causing concern about affordability.
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KEY FINDINGS FROM THE ACC MEMBER
SATISFACTION SURVEY
Between October 15, 2014, and November 12, 2014,
ACC conducted its annual online survey of members.
A total of 9,933 e-mail invitations were sent to ACC
members on October 15, 2014, and 3 reminders were
sent subsequently. A total of 1,042 members par-
ticipated in the survey, a 10.5% response rate.Respondents closely match overall ACC membership
demographics. Highlights from the 2014 Member
Satisfaction Survey, supplemented by 100 half-hour
interviews with selected members and results from
a monthly survey panel (CardioServe), are included
in the following ﬁndings.
The ACC membership is nearly 50,000 strong
worldwide. ACC member demographics are listed in
Figure 1.
CHALLENGES. Two-ﬁfths (40%) of members identify
reimbursement as the biggest issue facing cardiovas-
cular (CV) medicine. Challenges by percentage are
listed in Figure 2.
SATISFACTION. ACC members remain satisﬁed with
the ACC, see value for the price of their membership,
and are likely to recommend ACC membership to
others. Overall satisfaction with ACC at 74% and value
for price at 62% represent 8-year highs in those cate-
gories. Worldwide, ACC is second only to the European
Society of Cardiology (ESC) on key measures of mem-
ber satisfaction. If members could only choose one
association, over one-half (58%) would choose to be a
member of the ACC. The average of number of con-
current memberships in 2014 is 2.5 with the AHA and
the American College of Physicians being the top 2
concurrent memberships for ACC members. This has
fallen from a 2.9 average number of concurrent mem-
berships in 2012, indicating more selectivity.
The level of satisfaction for most members has not
changed, and if there were changes, they were more
likely to be increases in satisfaction rather than
decreases in satisfaction (Figure 3).
DESCRIPTIONS OF ACC MEMBERSHIP VALUE. Various
descriptions of membership value resonate with ACC
members. “The ACC is working to transform cardio-
vascular care and improve heart health” resonates the
most, followed closely by “The ACC is here to support
CV professionals from residency to retirement,” and
“The ACC is your professional home.”
IMPORTANCE OF ACC GOALS. Of the 10 cardiologists
interviewed, 9 believe that shaping the future of
public health policies and helping members thrive
and transform care any delivery or reimbursement
environment are the most important goals of the ACC.
Smartly using data, information, and knowledge to
accomplish organizational goals also resonates with
members, who realize the potential advantages of
using database registries such as the National Car-
diovascular Data Registry (Figure 4).
RECOMMENDING ACC. Of the ACC members, 70%
are likely or extremely likely to recommend ACC
membership to a team member.
FIGURE 1 Fall 2014 ACC Membership Proﬁle
MEMBER TYPE
BOARD
CERTIFICATION#
SPECIALITY†
GENDER
AGE
Fellow
Associate Fellow
INTL Associate
Fellow-in-Training (FIT)
INTL Fellow-in-Training
CCA
CCMA
AACC
STUDENT
Master
Partner-in-Care
Affiliate
Male
Female
30 or younger
Interventional
Electrophysiology
Pediatric Cardiology
General Surgery
Heart Failure/Transplant
Nuclear Medicine
# of Board Certified U.S.
Physicians (ACC Records)
No Board Certification
Cardiovascular Disease
Adult Cardiology
Nuclear Cardiology/Medicine
Pediatric Cardiology
Preventive Cardiology
Invasive Cardiology
Heart Failure/Transplant
Surgery
Non-invasive Cardiology
Adult Congenital Cardiology
Vascular Surgery/Medicine
MR/CT Cardiology
Geriatrics
Emergency Medicine
Public Health
No Specialty
Other
Echocardiology
Electrophysiology
Interventional Cardiology
Clinical Cardiology/General
Cardiology
Other
41-50
51-60
61-70
71 or older
31-40
Missing/Refused
Missing/No Data Provided
COUNT
COUNT
COUNT
49,435
Number of ACC Members
%
%
%
COUNT %
COUNT %
56%27,548
5,925
5,138
4,343
3,767
1,704
638
226
75
35,637
22,734
27,678
6,861
5,308
4,529
2,633
2,406
2,162
1,578
1,011
956
858
782
685
675
480
121
70
63
8,328
994
6,125
1,741
1,231
1,061
178
119
2,901
1,120
26,264°
1,101
10,828
7,484
5,377
10,180
8,312
6,153
72%
2%
78%
56%
14%
11%
9%
5%
5%
4%
3%
2%
2%
2%
2%
1%
1%
1%
0%
0%
0%
2%
17%
21%
6%
4%
4%
1%
0%
10%
4%
-
12%
17%
17%
22%
15%
11%
21%
11%
8,575
5,223
66
1
4
 12%
 10%
9%
8%
3%
1%
< 1%
< 1%
< 1%
< 1%
< 1%
ThenumberofAmericanCollegeof Cardiologymembers, 49,435, is detailed. Demographic breakdownsof themembership by count andpercentage, includingmember type,
gender, age, board certiﬁcation, and specialty, are detailed. †Members can select up to 3 specialties (primary, secondary, and tertiary), all members. Unique domestic
physiciansminus those listed as “NoBoard Certiﬁcation.” #Board certiﬁcations consist of domestic physicians only (Member Type:MA/FF/AF). AACC¼American Association
forClinical Chemistry; CCA¼ cardiac care associate; CCMA¼ clinical certiﬁedmedical assistant; CT¼ computed tomography; INTL¼ international;MR¼magnetic resonance.
Source: American College of Cardiology Member Database October/November 2014.
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D4VALUABLE ACC BENEFITS. Access to the JACC pub-
lications and clinical guidelines are the most valuable
member beneﬁts. The ACC website also provides high
value followed by educational resources (including
access to over 300 complimentary MOC activities) and
representation in both government and certiﬁcation-
related arenas (Figure 5).
VALUE OF FACC. More than 2 out of 3 cardiologists
consider the FACC designation to be very/extremely
valuable, with cardiologists in private practice and/or
practicing internationally ﬁnding these designations
most valuable. Slightly fewer (62%) say that it is very
important to their institution that a cardiologist be an
FACC. Moreover, almost three-quarters of hospital
administrators and CV directors reported they
were more likely to hire an FACC to ﬁll their cardiolo-
gist positions. Almost all fellows (90%) post their
designations.
HOW ACC MEMBERS ENGAGE. Three-year trend ﬁg-
ures show dues payment tops the list of howmembers engage, followed by use of the website. Paid
section membership, collecting continuing medical
education (CME), attending live programs, purchas-
ing products, and attending the annual meeting are
also ways that members engage. Less popular are
committee participation and donating. Only 8% of
members have donated to the political action com-
mittee in the past 5 years. Most donations were a
single donation (50%), while 10% gave to the political
action committee annually.
EXPRESSED NEEDS. Members expressed the desire
for more help from ACC in areas including:
 Advocacy: ABIM MOC requirements and cuts in
reimbursements
 Education: MOC, self-assessment products, and
patient education materials
 Short/Simple/Quick: summary of detailed infor-
mation and concise tools and guidelines
 Ease of Use: easier access to journals and guidelines
FIGURE 2 Biggest Challenges in CV Medicine
1%
2%
3%
5%
5%
6%
8%
8%
9%
10%
10%
11%
12%
12%
13%
16%
18%
18%
24%
26%
30%
40%
0% 5% 10% 15% 20% 25% 30% 35% 40% 45%
Not sure
NA/I do not practice medicine
Other
Tort reform
Access to quality tools and guidelines
Malpractice/Professional insurance
Patient treatment adherence
Hospital integration
Accountable Care Organization
Clinical topics
Changing practice ownership structure – from private to hospital
Quality of care
Funding for academic/research/training programs
Communication/Information overload
Appropriate Use Criteria
Government regulation/Autonomy
EMR/Electronic health record
Keeping up–to–date from a clinical standpoint
Costs/Rising costs/Bundled payments
Certification/MOC/Training
Work–life balance, extensive work load/work hours
Reimbursement/Payment cuts/Medicare/Medicaid
Two fifths (40%) of members identify reimbursement as the biggest issue facing CV medicine. Work–life balance (30%),
certification/MOC (26%), and costs/rising costs/bundled payments (24%) are also challenges.
50%
A list of biggest challenges for respondents to the American College of Cardiology 2014 Membership Satisfaction Survey. Challenges are listed
by percentage of responses. EMR ¼ electronic medical record; MOC ¼ Maintenance of Certiﬁcation; NA ¼ not applicable. Source: American
College of Cardiology 2014 Member Satisfaction Survey.
FIGURE 3 Changes in Member Satisfaction
Has not changed
65% 
Decreased
12%
Increased
23%
Advocacy (e.g., ABIM, MOC)
High dues/costs
Not enough sub–specialty focus
Not enough international focus
Advocacy (e.g., ABIM, MOC)
Conferences
ACC website
Educational materials/programs
The new JACC
Guidelines
Focus on sub–specialty
Almost two thirds (65%) of members report that their satisfaction with the ACC has not changed over the past year.
This ﬁgure details changes in member satisfaction for respondents to the American College of Cardiology 2014 Membership Satisfaction Survey.
Changes are from the 2013 Survey to the 2014 Survey. Increase (and key reasons), decrease (and key reasons), and no change percentages are
detailed in graphs. ABIM ¼ American Board of Internal Medicine; ACC ¼ American College of Cardiology; JACC ¼ Journal of the American
College of Cardiology; MOC ¼ Maintenance of Certiﬁcation. Source: American College of Cardiology 2014 Member Satisfaction Survey.
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FIGURE 4 Importance of ACC Goals
Shape the future of public health policies
Help members thrive and transform care in
any delivery/reimbursement environment
Smartly use data, information, and knowledge
Support members in their expanded accountability
Become even more focused on member value
Leverage technology/forge partnerships
to personalize education
Very
Important
Extremely
Important
25% 65%
28% 62%
31% 51%
28% 49%
31% 43%
37% 34%
90%
90%
82%
77%
74%
71%
This ﬁgure details the importance levels of American College of Cardiology goals from respondents to the American College of Cardiology 2014
Member Satisfaction Survey. Listed by goal importance in percentages. Color graphic representation where blue ¼ very important and orange ¼
extremely important. Source: American College of Cardiology CardioServe Panel Survey, September 2014, n ¼ 150.
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D6 Updates: e-mail updates on CV issues, clinical updates
 Subspecialty Focus: more targeted clinical information
EMERGING PAYMENT REFORM
SLOWING OF GROWTH IN HEALTHCARE COST. The
years 2011, 2012, and 2013 registered the slowest
growth in real per capita national health expenditures
on record, and slow growth continued into 2014 (1).
VARIETY OF VALUE-BASED PAYMENT PROGRAMS
DRAWS PROVIDER PARTICIPATION. Medicare is
engaged in testing payment and service delivery
models with more than 60,000 healthcare pro-
viders, affecting an estimated 2.5 million Medicare,
Medicaid, and Children’s Health Insurance Program
(CHIP) beneﬁciaries (1).
Accountable Care Organizat ions (ACOs) . There
are 424 organizations currently participating in Medi-
care ACOs covering more than 7.8 million Medicare
beneﬁciaries. Participation in ACOs is voluntary, and
these programs have varying levels of provider risk and
reward. As existing ACOs addmore providers andmore
organizations join existing and newer ACO models,
participation in ACOs is expected to grow further (1).
Medicare Advantage plans . The ACA ties payment
to private Medicare Advantage plans to quality rat-
ings (1 to 5 stars). Approximately 40% of Medicare
Advantage contracts received 4 or more stars in 2015,
an increase from 6% in 2013 (1).
Bundled Payments . The Bundled Payments for Care
initiativecurrentlyhas870participants representing6,424providers in Phase I (preparation) and 105 participants
representing 243 providers in Phase II (risk-bearing) (1).
CMS PLAN TO ACCELERATE SHIFT TOWARD VALUE-
BASED PAYMENTS. On January 26, 2015, Health and
Human Services (HHS) Secretary Sylvia M. Burwell
announced a set of measurable goals and a timeline to
accelerate the shift toward value-based payment of
healthcare providers. HHS has set the goal of tying 30%
of Medicare payments to value-based models, such as
ACOs, pay for performance, or bundled payment ar-
rangements, by the end of 2016 and tying 50% of
Medicare payments to thesemodels by the end of 2018.
To make these goals scalable beyond Medicare, Sec-
retary Burwell also announced the creation of the
Health Care Payment Learning and Action Network.
Through the Learning and Action Network, HHS will
“work with private payers, employers, consumers,
providers, states and state Medicaid programs, and
other partners to expand alternative payment models
into their programs” (2) (Figure 6).
HHS has adopted a framework that categorizes
healthcare payment according to how providers
receive payment to provide care (3) (Figure 7).
 Category 1: fee-for-service with no link of payment
to quality
 Category 2: fee-for-service with a link of payment
to quality
 Category 3: alternative payment models built on
fee-for-service architecture
 Category 4: population-based payment
FIGURE 5 Most Valuable ACC Beneﬁts
2%
4%
1%
3%
9%
9%
9%
11%
17%
18%
18%
18%
19%
23%
24%
27%
28%
44%
64%
68%
0% 10% 20% 30% 40% 50% 60% 70%
None of these
All of these
Other
Discounted programs with third–party vendors
Mentoring and leadership tools, resources, and opportunities
Access to more than 40,000 research opportunities
Access to more than 80 state and international chapters
Reimbursement and payor provision advocacy
Participation in ACC’s member sections
Legislative and regulatory advocacy at federal and state levels
Discounts on ACC’s Digital Products (ACCSAP, EchoSAP, CathSAP)
Access to ACC’s Quality Initiatives
Supporting cardiovascular professionals in their career growth/path
Representation on professional issues, certification/MOC
Access to mobile applications
Registration discounts on the Annual Scientific Sessions and ACC live courses
Access to over 300 complimentary MOC activities
ACC website
Access to clinical guidelines, Appropriate Use Criteria, Consensus Docs
Access to JACC publications
Access to JACC and guidelines are the most valuable member benefits. The ACC website also provides value followed by
educational resources (MOC, ACC.XX, mobile apps) and professional representation.
This ﬁgure details the most valuable member beneﬁts from respondents to the American College of Cardiology 2014 Member Satisfaction Survey. Responses are listed
from most valuable to least valuable by percentage with graphic representation. ACC ¼ American College of Cardiology; ACCSAP, EchoSAP, CathSAP ¼ program
self-assessment products from the American College of Cardiology; JACC ¼ Journal of the American College of Cardiology; MOC ¼ Maintenance of Certiﬁcation. Source:
American College of Cardiology 2014 Member Satisfaction Survey.
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D7CMS VALUE-BASED PAYMENT MODIFIER IN 2015
AND 2016. Beginning in calendar year 2015, Medicare
will apply the Value Modiﬁer to physician payments
under the Medicare Physician Fee schedule for
participating and nonparticipating physicians in
groups of 100 or more eligible professionals for the
2013 performance period.
Medicare will accelerate this approach in 2016,
applying the Value Modiﬁer to groups of 10 or more
eligible professionals for the calendar year 2014 per-
formance period.
The overall approach to implementing the Value
Modiﬁer is based on participation in the Physician
Quality Reporting System (PQRS). Groups of physicians
with 100 or more eligible professionals in 2015 and 10 or
more eligible professionals in 2016 must participate in
PQRS by self-nominating/registering for PQRS as a group
and reporting at least 1 measure, or electing PQRS
Administrative Claims Option to avoid the 1% down-
ward Value Modiﬁer payment adjustment. As an alter-
native, groups can elect to have their Value Modiﬁer
calculated using the quality-tiering methodology. For
groups that make this election, Medicare will use theperformance rates on the quality measures reported
through PQRS reporting mechanisms (such as group
practice reporting optional web interface or CMS quali-
ﬁed registries) and 3 outcomemeasures to calculate their
Value Modiﬁer resulting in upward, downward, or no
payment adjustment based on performance (4).
CMS “NEXT GENERATION” ACO MODEL. On March
10, 2015, CMS announced a next generation voluntary
ACO model that differs from the existing Medicare
Shared Savings Program and Pioneer ACO models in
several different ways:
 Provides higher levels of risk and reward than
either the Medicare Shared Savings Program or the
Pioneer ACO Model, using what CMS characterizes
as more stable, predictable benchmarking methods
that reward both attainment and improvement in
cost containment;
 Offers a selection of payment mechanisms to shift
from fee-for-service reimbursement to capitation;
and
 Includes “beneﬁt enhancement” tools to im-
prove engagement with beneﬁciaries, including:
FIGURE 6 Target Percentage of Medicare FFS Payments Linked to Quality and Alternative Payment Models in 2016 and 2018
All Medicare FFS (Categories 1–4)
FFS linked to quality (Categories 2–4)
Alternative payment models (Categories 3–4)
2016 2018
All Medicare FFS All Medicare FFS
85% 90%
30% 50%
This ﬁgure details percentages of Medicare payments to Medicare Fee for Service (blue), for Fee for Service linked to Quality (orange), and for
Alternative Payment Models (grey) for years 2016 and 2018. FFS ¼ fee for service. Source: “Better Care. Smarter Spending. Healthier People:
Paying Providers for Value, not Volume.” n.d. Centers for Medicare and Medicaid Services fact sheet, Web, 27 Mar 2015.
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D81) greater access to home visits, tele-health ser-
vices, and skilled nursing facilities; and 2) oppor-
tunities to receive a reward payment for receiving
care from the ACO (5).
ACC’s SMARTCare PROGRAM IN FIRST YEAR OF
3-YEAR PILOT. Cardiologists in Wisconsin and Flor-
ida, working through the ACC, are in the ﬁrst year of a
3-year pilot funded by a CMS Medicaid Innovation
Grant. The Center for Payment Reform and the Part-
nership for Healthcare Quality and Payment Reform
have been providing technical assistance. The pilot is
intended to model better care for patients with stable
ischemic heart disease.
The pilot uses an ACC electronic decision-support
tool called FOCUS that is based on ACC appropriate
use criteria. The FOCUS tool will inform and support
decision making by the patient and the physician
about the most appropriate care, but will not dictate a
particular approach. Other tools available for use in
the program include the ePRISM decision support
software and the INDIGO risk management software.
The choices made by physicians and patients will be
recorded and analyzed in 2 important ways.
 Individual physicians will receive feedback on
their own ordering patterns. For example, if a
physician had a high rate of ordering stress
tests for patients where those tests “may be”appropriate, the physician would be able to see
whether other physicians were achieving similar or
better results for similar patients by using fewer
tests or less risky and invasive tests.
 Appropriate use improvement will be fostered.
Through SMARTCare, the teams of physicians who
develop and maintain the appropriate use criteria
will have more detailed data available to use for
reﬁning the criteria and providing clearer guidance
as to which tests and procedures are likely appro-
priate or inappropriate in more unusual cases. The
data collected will be added to the PINNACLE
registry and the National Cardiovascular Data
Registry to support research about outcomes and
the reﬁnement of existing criteria (6).
NATIONAL SCORECARD ON PAYMENT REFORM AND
VALUE-BASED PAYMENT SHIFT. On September 30,
2014, the most recent National Scorecard on Payment
Reform showed a signiﬁcant increase in the adoption
of value-based payment methods by private payers in
the United States. The Scorecard is published on an
annual basis by Catalyst for Payment Reform, an in-
dependent, nonproﬁt employer coalition. The report
showed that commercial healthcare plans are dra-
matically shifting how they pay physicians and hos-
pitals with 40% of payments now based on some form
of value-based care, far ahead of the original goal set
FIGURE 7 Payment Taxonomy Framework
Category 1: Category 2: Category 3: Category 4:
Fee for Service—
No Link to Quality
Fee for Service—
Link to Quality
Alternative Payment
Models Built on Fee–for–
Service Architecture
Population–Based Payment
Payments are based on
volume of services and
not linked to quality or
efficiency.
De
sc
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n
M
ed
ic
ar
e 
FF
S
At least a portion of
payments vary based on
the quality or efficiency of
healthcare delivery.
Some payment is linked to
the effective management
of a population or an
episode of care. Payments
still triggered by delivery
of services, but
opportunities exist for 
shared savings or 
2–sided risk.
Payment is not directly
triggered by service delivery
so volume is not linked to
payment. Clinicians and
organizations are paid and
responsible for the care of a
beneficiary for a long period
(e.g. ≥1 yr).
Limited in Medicare
fee for service
Majority of Medicare
payments now are
linked to quality.
Hospital value–based
purchasing
Physician Value–
Based Modifier
Readmissions/Hospital
Acquired
Condition Reduction
Program
Accountable care
organizations
Medical homes
Bundled payments
Comprehensive
primary care
initiative
Comprehensive
ESRD
Medicare–Medicaid
Financial Alignment
Initiative Fee–For–
Service Model
Eligible Pioneer
accountable care
organizations in
years 3–5
This ﬁgure details the presentation of types of Medicare payment programs listing 4 categories: Fee for Service—No Link to Quality, Fee for
Service—Link to Quality, Alternative Payment Models Built on Fee-for-Service Architecture, and Population-Based Payment. Table includes
description and relation to Medicare fee for service for each category. ESRD ¼ end stage renal disease; FFS ¼ fee for service. Source: “Better
Care. Smarter Spending. Healthier People: Paying Providers for Value, Not Volume.” n.d. Centers for Medicare and Medicaid Services fact sheet,
Web. 27 Mar. 2015.
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D9by the Catalyst for Payment Reform. The 2014
Scorecard shows a 29 percentage point increase over
2013, when just 11% of payments were value-oriented.
Just over one-half (53%) of the payments that are
value-oriented put providers at some ﬁnancial risk if
they fail to provide care or spend over budget. Much
of the value-oriented payment is in pay-for-perfor-
mance arrangements with providers, offering only
potential ﬁnancial reward and no ﬁnancial risk.
Hospitals are most impacted by value-oriented pay-
ment programs with 38% of payments, compared
with the outpatient setting where 10% of payments to
specialists and 24% of payments to primary care
physicians are value oriented (7).
ACC MEMBERS AND VALUE-BASED PERFORMANCE
AS A MAJOR AREA OF FOCUS. Value-based perfor-
mance follows increasing the efﬁciency of practices
and billing coding issues as major areas of practice
focus for ACC members over the next 3 to 5 years (8)
(Figure 8).ACC MEMBERS FAMILIARITYWITH AND PARTICIPATION
IN ACOs ON THE RISE. ACC member familiarity with
and participation in ACOs jumped signiﬁcantly from
2011 to 2014. Familiarity with ACOs increased from
44% to 58% and participation in ACOs increased
from 1% to 20% in that time period. Of ACC members
surveyed, 33% of those familiar are very or extremely
likely to join an ACO (9).
IN HISTORIC VOTE, SGR IS REPEALED. On April 16,
2015, President Obama signed into law the Medicare
Access and CHIP Reauthorization Act. The law
permanently repeals the SGR formula and establishes
a framework for rewarding physicians for high-
quality care, streamlines quality-reporting programs
into one system, and reauthorizes funding for CHIP.
The law replaces the SGR with a plan to give clinicians
an increase of 0.5% in each of the next 5 years as
Medicare transitions to a system designed to reward
physicians on the quality of care delivered rather than
the quantity of services performed. The law does not
FIGURE 8 Practice Efﬁciency Major Areas of Focus in
Next 3 to 5 Years
Increasing practice efficiency (59%)
Billing and coding Issues (48%)
Value–based performance (40%)
Exploring different business models (37%)
Government regulations (37%)
Adopting technology to improve clinical decision making (31%)
Major areas of focus for practice efﬁciency in the next 3 to 5 years
for American College of Cardiology members responding to a
panel survey. Listed in descending order of response percentage.
Source: American College of Cardiology CardioServe member
panel survey, February 2014.
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D10require participation in MOC programs, nor does it
establish any speciﬁc entity to administer MOC (10).
CHANGES IN CERTIFICATION AND
RECERTIFICATION REQUIREMENTS
JAMA STUDY FINDS LACK OF SUPPORT FOR MOC. A
study headed by researchers at the Mayo Clinic and
published January 2015 in the Journal of the American
Medical Association Internal Medicine (JAMA) found
that physicians believe that MOC requirements are
cumbersome and provide little to no professional
gain. In a grounded theory focus group study of 50
board-certiﬁed primary care and subspecialist inter-
nal medicine and family medicine physicians in an
academic medical center and outlying community
sites, participants identiﬁed gaps between the
espoused purposes of MOC (e.g., to promote high-
quality care, commitment to the profession, lifelong
learning, and the science of quality improvement)
and MOC as currently implemented. Participants in
the JAMA study perceived MOC as being inefﬁcient,
logistically difﬁcult for learning and assessment,
often irrelevant to practice, and of little beneﬁt to
physicians, patients, or society (11).
ACC DETAILS CARDIOLOGY PARTICIPATION IN MOC.
ACC President Patrick T. O’Gara, MD, FACC, and
Executive Vice President William Oetgen, MD, MBA,
FACC, outlined in JACC the continuing efforts of the
College to encourage ABIM to modify the MOC pro-
cess. The journal article reported on the current sta-
tus of MOC participation among CVD diplomates of
the ABIM (12).
A survey conducted in September 2014 docu-
mented the MOC participation of ACC leadership.
Of ABIM diplomates who are members of the ACCBoard of Trustees, 100% are participating in MOC. Of
ABIM diplomates who are members of the ACC Board
of Governors, 92% are participating in MOC (12).
A more comprehensive look at ACC member
participation in MOC activities in September 2014
showed 25,799 CVD diplomates on the ABIM rolls. Of
these cardiologists, 74% were enrolled in MOC. By
comparison, 68% of ABIM diplomates in internal
medicine, 70% of diplomates in gastroenterology, and
73% of diplomates in oncology were enrolled in MOC.
With respect to cardiology subspecialties, 86% of
interventional cardiology specialists, 85% of electro-
physiology specialists, and 87% of heart failure
specialists were enrolled in MOC (12) (Figure 9).
NEW ENGLAND JOURNAL OF MEDICINE (NEJM)
PUBLISHES PERSPECTIVES IN MOC DEBATE. In
January 2015, the NEJM published 2 contrasting per-
spectives in the ongoing controversy over the new
ABIM MOC program. The articles reﬂect the tension
between the American Board of Medical Specialties
and ABIM missions to assure the public of profes-
sional commitments to integrity and accountability
and the concern by physicians and their medical so-
cieties that the methods chosen to revise MOC have
not been fully validated.
The ﬁrst perspective, by Mira B. Irons, MD, and
Lois M. Nora, MD, JD, MBA, representatives of the
ABIM, details the history of the MOC and how the
recently approved changes to the standards were
developed. They note that the standards were modi-
ﬁed after a comprehensive 2-year review, and they
point out that “high standards of specialty certiﬁca-
tion are important to healthcare.” The authors “hope
our medical community partners will work with us to
continue to evolve our certiﬁcation systems to ensure
the standards they set continue to be highly valued in
the future” (13).
In the second perspective, Paul S. Teirstein, MD,
FACC, notes “many physicians are waking up to the
fact that our profession is increasingly controlled by
people not directly involved in patient care who
have lost contact with the realities of day-to-day
clinical practice. Perhaps it’s time for practicing
physicians to take back the leadership of medicine.”
Teirstein is founder of The National Board of Phy-
sicians and Surgeons, an alternative certiﬁcation
organization (14).
FINANCIAL IMPACT OF MOC ON MEDICAL BOARDS
REVIEWED. A study in theDermatology Online Journal
focused on an analysis of publicly available Internal
Revenue Service (IRS) form 990s of medical boards,
revealing a general trend of increased revenue and
end-of-year balance for the majority of the ABMS
FIGURE 9 ABIM Cardiovascular Disease Diplomats, September 2014
25,000
20,000
15,000
10,000
5,000
CV “GP” EP IV HF
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Total Diplomats MOC Enrolled % Enrolled
This ﬁgure details the total ABIM cardiovascular diplomats, number enrolled
in MOC activities, and percentage enrolled in MOC Activities including ﬁgures
for cardiovascular subspecialties. CV ¼ all cardiovascular diplomates;
EP¼ electrophysiologists; “GP”¼ grandparents; HF ¼ heart failure specialists;
IV ¼ interventionalists; MOC ¼Maintenance of Certiﬁcation. Source: ”O’Gara,
Patrick T., MD, FACC. “Follow-Up on ABIM Maintenance of Certiﬁcation.”
Journal of the American College of Cardiology 65.2 (2015): n. pag. Web.
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D11and its 24medical boards after the 2006 approval of the
ABMS MOC requirements. While exceptions do exist,
the study’s authors point out that the majority of the
medical boards have beneﬁted ﬁnancially from the
establishment of MOC (15).
ABIM ANNOUNCES SUBSTANTIAL CHANGES TO MOC
PROGRAM IN RESPONSE TO CONTROVERSY. On
February 3, 2015, the ABIM announced substantial
changes to its MOC program and indicated a desire to
work more closely with the internal medicine com-
munity. The organization apologized by saying, “ABIM
clearly got it wrong. We launched programs that
weren’t ready and we didn’t deliver an MOC program
that physicians found meaningful.” ABIM said the
changes announced in 2014 had generated legitimate
criticism among internists and medical specialty soci-
eties. ABIM announced the following steps:
 Effective immediately, ABIM is suspending the
Practice Assessment, Patient Voice, and Patient
Safety requirements for at least 2 years. This means
that no internist will have his or her certiﬁcation
status changed for not having completed activities
in these areas for at least the next 2 years. Diplo-
mats who currently are not certiﬁed but who have
satisﬁed all requirements for MOC except for the
Practice Assessment requirement will be issued a
new certiﬁcate this year.
 By August 2015, ABIM would change the language
used to publicly report a diplomat’s MOC status on
its website from “meeting MOC requirements” to
“participating in MOC.”
 ABIM is updating the Internal Medicine MOC
exam. The update will focus on making the exam
more reﬂective of what physicians in practice
are doing, with any changes to be incorporated
beginning fall 2015, with more subspecialties to
follow.
 MOC enrollment fees will remain at or below the
2014 levels through at least 2017.
 By the end of 2015, ABIM will ensure new and more
ﬂexible ways for internists to demonstrate self-
assessment of medical knowledge by recognizing
most forms of ACCME–approved CME.
In June of 2015, ABIM announced the elimination
of a requirement to maintain underlying certiﬁcation
in a foundation discipline in order to remain certiﬁed
in a subspecialty. For cardiology, this elimination of
the “double jeopardy” provision means that those
specializing in interventional, electrophysiology,
adult congenital, and advanced heart failure will no
longer need to pass both the general cardiology and
subspecialty boards to maintain certiﬁcation (16).ABIM is promising to work with medical societies
and directly with diplomats to seek input regarding
the MOC program through meetings, webinars, fo-
rums, online communications channels, surveys, and
more. ABIM stated, “It remains important for physi-
cians to have publicly recognizable ways—designed
by internists—to demonstrate their knowledge of
medicine and its practice. Internists are justiﬁably
proud of their knowledge and skills” (17).
ACC President Patrick O’Gara said the ABIM deci-
sion comes as “welcome news to the internal medi-
cine community.” O’Gara added that “last year’s
signiﬁcant changes to the program generated legiti-
mate criticism and sparked heated discussions—
including among members of the cardiovascular
community.” The changes announced today are
encouraging, and the ABIM should be recognized
for listening to physicians and specialty societies,
including the ACC (18).
CERTIFICATION CONTROVERSY REACHES GENERAL
PUBLIC. In the spring of 2015, a series of editorials
in the national consumer magazine, Newsweek, and
responses from ABIM pushed the certiﬁcation con-
troversy into the realm of the general public. A March
10, 2015, Newsweek editorial by Kurt Eichenwald
detailed the controversy as a “bizarre war, one that
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D12could transform medicine for years.” Eichenwald
recounted the ABIM decision to change its MOC pro-
gram and the opposition from “tens of thousands of
internists, cardiologists, kidney specialists and the
like who say the ABIM has forced them to do busy-
work that serves no purpose other than to fatten the
board’s bloated coffers.” He detailed the history of
certiﬁcation and the expansion to recertiﬁcation that
required additional testing over time. Eichenwald
reported that according to some physicians, the tests
were often outdated and not relevant to the physi-
cians’ practices, resulting in a steady drop in the
percentage of doctors passing recertiﬁcation exams.
He focused on ABIM’s ﬁnances, comparing ABIM’s
revenue in 2001 at $16 million and total compensation
for top ofﬁcers and directors of $1.3 million to reve-
nue at the end of 2013 of $55 million and a quadru-
pling of pay for top ofﬁcers and directors (19).
ABIM quickly took issue with the ﬁrst Newsweek
article in a statement from Board Chairman David H.
Johnson, stating that the article “contains numerous
and serious misstatements, selective omissions,
inaccurate information and erroneous reporting.”
ABIM disputed Eichenwald’s reporting of a steady
drop in the percentage of physicians passing recerti-
ﬁcation exams, saying that passing percentages in
fact “rise and fall over the years and across disci-
plines” and pointing out that in total, 96% of physi-
cians whom ABIM certiﬁes passed an exam to
maintain their certiﬁcations. ABIM also took issue
with Eichenwald’s assertion that ABIM has a mo-
nopoly on certifying internists, stating, “In reality
internists have a choice among certifying boards that
certify internal medicine and its subspecialties” (20).
A follow-up Newsweek editorial by Eichenwald
suggested that the ABIM’s expansion of MOC is in
response to the organization’s severe ﬁnancial crises,
which are caused by questionable accounting prac-
tices. He also reported that congressional passage of
legislation designed to rectify problems caused by the
SGR formula includes a provision to require partici-
pation in MOC (21).
The ACC, in an April 10, 2015 letter to its members,
refuted what it called “speculation and misinforma-
tion that is a potentially damaging distraction” from
the effort to repeal the SGR. The ACC said the House
legislation “does not require participation in mainte-
nance of certiﬁcation (MOC), nor does it establish
ABMS, ABIM or any speciﬁc entity to administer MOC.
No one would be forced to participate in MOC” (22).
MAINTENANCE OF LICENSURE IMPACT. The Feder-
ation of State Medical Boards continues to develop
and pilot test a framework for Maintenance ofLicensure. A current fact sheet from the organization
says Maintenance of Licensure is still years away from
being adopted by any state medical board. The
framework being proposed by the Federation of State
Medical Boards would not require examinations to
comply with Maintenance of Licensure. State medical
boards also do not require specialty certiﬁcation or
recertiﬁcation for licensure or licensure renewal, and
that is not expected to change (23).
IMPACT OF MULTIPLE CERTIFICATIONS. Fellow-in-
Training Ryan J. Maybrook, MD, in a recent article in
JACC, gives an early career view of a “new, less-stable
world of cardiovascular medicine.” Maybrook ex-
presses concerns about a future career consisting of
“expensive board review courses and endless recer-
tiﬁcation exams.” Maybrook suggests that questions
about the viability of taking multiple board exams
revolve around affordability, motivation for taking
the exams, and the effect they have on one’s career,
with the overarching question of “What kind of
cardiologist am I building?” He includes an overview
of general and subspecialty cardiovascular board
certiﬁcation exams detailed in Figure 10 (24).
HEALTHCARE REFORM
NEARLY 12 MILLION ENROLL IN 2015 HEALTH INSURANCE
MARKETPLACE. HHS announced that 11.7 million
American consumers selected or were automatically
re-enrolled in health insurance coverage through the
Health Insurance Marketplace as of February 22, 2015.
Of those, 8.84 million (76%) were in states using the
HealthCare.gov platform and 2.85 million (24%) were
in the 14 states (including Washington, DC) using
their own Marketplace platforms. Highlights of the
announcement included:
 More than 4.1 million consumers under the age
of 35 are signed up for Marketplace coverage.
 Of the more than 8.8 million plan selections
in HealthCare.gov states, 87% (nearly 7.7 million
individuals) qualiﬁed for an average tax credit of
$263 per month.
 More than one-half of the individuals selected a
plan with a premium of $100 or less after tax
credits (25).
ACA MARKS FIFTH ANNIVERSARY WITH HISTORIC
REDUCTION IN THE UNINSURED RATE. As the ACA
marked its ﬁfth anniversary, data from the Gallup
HealthWays Well-Being Index showed a historic
reduction in the number of Americans without health
insurance. Since the ACA coverage provisions took
effect, approximately 16.4 million uninsured people
FIGURE 10 Overview of General and Subspecialty Cardiovascular Board Certiﬁcation Examinations: Cost and Statistics
Board Examination
Date of First
Examination
Initial Certification
Examination Fee
Total Number of
Test Takers for
Initial Certification
Exam
Percent Passing
(Obtaining
Certification) at Initial
Certification Exam MOC Fee*
MOC Exam
Interval
Yearly
Maintenance Fee
Upgrade Fees/
Other Fees Additional Information
ABIM Internal
Medicine
1936 $1,365 7,482 (2013) 86% (2013) Exams are included in
MOC fee (first retake
is $400, additional
retakes are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
Not required to
maintain
certification in
Cardiovascular Disease
ABIM
Cardiovascular
Disease†
1941 $2,345 825 (2013) 95% (2013) Exams are included in
MOC fee (first
retake is $400,
additional retakes
are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
ABIM Clinical
Cardiac
Electrophysiology
1992 $2,830 141 (2013) 86% (2013) Exams are included in
MOC fee (first retake
is $400, additional
retakes are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
ABIM Interventional
Cardiology
1999 $2,830 311 (2013) 92% (2013) Exams are included
in MOC fee (first
retake is $400,
additional retakes
are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
ABIM Advanced
Heart Failure
and Transplant
Cardiology
2010 $2,830 287 (2012) 83% (2012) Exams are included in
MOC fee (first retake
is $400, additional
retakes are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
ABIM Adult
Congenital
Heart Disease
(beginning 2015)
2015 $2,830 First exam
in 2015
Pilot exam to
be administered
2015
Exams are included in
MOC fee (first
retake is $400,
additional retakes
are $775)*
10 yrs Part of MOC $500 fee if exam
taken at an
international
testing center
PVI by ARDMS (for
RPVI Certification)
January 2006
(pilot test in
September 2005)
$600 Not stated
on Website
90% (2013) $0 10 yrs $100
008$8991HSA
($650 for
ASH members)
Not stated
on Website
Not stated on
Website
Same as initial fee 10 yrs N/A
ASCeXAM by NBE 1995 (field test)‡ $995 1,261 (2014) 68% (2014) $595 10 yrs N/A $175 (upgrade from
Testamur to
Certified status)
CBNC by CCCVI 1996 $995 682 (2013) 79.4% (2013) $725 10 yrs and
2 months
N/A $50 multi-modality
discount if also
sitting for CBCCT
in same year
CBCCT by CCCVI 2008 $950 188 (2013) 85.1% (2013) Not stated
on Website
10 yrs N/A Multi-modality
discount (see
CBNC)
ABCL November 2005 $1,200 Not stated
on Website
~75%-80% per
Website
$1,250 10 yrs $100
*If enrolled in MOC prior to 2014, 1 exam was included in the 10-year fee; additional examinations are $775. †With the current regulations, if a physician was certified by taking the certification examination prior to 1990, that physician is “grandfathered” and never has
to take the examination again. However, a physician certified after 1990 has to repeat examinations every 10 years to maintain certification. ‡1995 field test given under the auspices of ASE; 1996 test also administered under the auspices of ASE; 1997 and 1998
examinations given under the auspices of ASCeXAM, Inc.; 1999 and forward under NBE.
Chart details cardiovascular-related board certiﬁcation examinations, including exam sponsor, date of ﬁrst exam, initial exam fee, total number of test takers for ﬁrst exam, percent passing initial exam, maintenance of
certiﬁcation fee, maintenance of certiﬁcation exam interval, yearly maintenance fee, upgrade and other fees, and additional information. ABCL ¼ American Board of Clinical Lipidology; ABIM ¼ American Board of Internal
Medicine; ARDMS ¼ American Registry for Diagnostic Medical Sonography; ASCeXAM ¼ National Board of Echocardiography Board Certiﬁcation Exam in Echocardiography; ASE ¼ American Society of Echocardiography;
ASH ¼ American Society of Hypertension, Inc.; CBCCT ¼ Certiﬁcation Board of Cardiovascular Computed Tomography; CBNC ¼ Certiﬁcation Board of Nuclear Cardiology; CCCVI ¼ Council for Certiﬁcation in Cardiovascular
Imaging; MOC ¼Maintenance of Certiﬁcation; NBE ¼ National Board of Echocardiography; PVI ¼ Physicians’ Vascular Interpretation; RPVI ¼ Registered Physician in Vascular Interpretation. Source: Maybrook, Ryan M., MD.
“Build-a-Cardiologist: The Cardiologist of the Future—The Business of Certiﬁcation.” Journal of the American College of Cardiology 65.12 (2015):1258-262, Web, 16 Apr. 2015.
J
A
C
C
V
O
L
.
6
6
,
N
O
.
1
9
,
S
U
P
P
L
D
,
2
0
1
5
Laslett
et
al.
N
O
V
E
M
B
E
R
1
0
,
2
0
15
:D
1
–
4
4
20
15
A
CC
Environm
ental
Scanning
R
eport
D
13
FIGURE 11 Percentage of U.S. Adults Without Health Insurance by Quarter
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This ﬁgure details the percentages of uninsured in United States. Time covered in graph is ﬁrst quarter 2008 to fourth quarter 2014.
Source: Gallup-Healthways Survey Data through March 4, 2015.
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D14have gained health insurance coverage, and the
uninsured rate stands at a low of 12.9% for the fourth
quarter of 2014. This uninsured rate is down slightly
from a 13.4% rate in the third quarter of 2014 and
down signiﬁcantly from a 17.1% rate in the ﬁrstFIGURE 12 Additional Detail on Coverage Gains Since the Start of th
Uninsured Rates by Race and Ethnicity
Baseline
Uninsured
Rate
Whites
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Americans
Latinos
C
14.3
22.4
41.8
The uninsured rate declined across all race/ethnicity categ
decline among African Americans and Latinos than among
Among Whites, the uninsured rate declined by 5.3 pe
14.3 percent, resulting in 6.6 million adults gaining co
Among African Americans, the uninsured rate decline
rate of 22.4 percent, resulting in 2.3 million adults ga
Among Latinos, the uninsured rate dropped by 12.3 p
41.8 percent, resulting in 4.2 million adults gaining co
This ﬁgure gives baseline of uninsured rate for Whites, African American
Q1 2014, Q3 2014, and Q1 2015. All models use nationally representative
household income, and state of residence,  a linear trend. Source: “Ana
Assistant Secretary for Planning and Evaluation (ASPE), U.S. Departmenquarter of 2014 (26). Figure 11 details the change in the
uninsured rate from the ﬁrst quarter in 2008 through
the fourth quarter in 2014. Figure 12 shows additional
detail on percentage drops in the uninsured rate by
race and ethnicity.e First Open Enrollment Period in October 2013:
Q1 2014 Q3 2014 Q1 2015
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FIGURE 13 Public Opinion of Affordable Care Act From 2010 to 2015
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D15HOSPITALS SAVE BILLIONS IN UNCOMPENSATED
COSTS IN 2014. On March 23, 2015, HHS Secretary
Silvia Burwell announced that U.S. hospitals saved
$7.4 billion in uncompensated care costs in 2014
as a result of patient enrollment through the
health insurance exchanges and Medicaid. HHS
attributes $5 billion of the savings to Medicaid
expansion (27).
GAP BETWEEN FAVORABLE AND UNFAVORABLE
OPINIONS OF ACA NARROWS. An April 2015 Kaiser
Family Foundation tracking poll found that the gap
between favorable and unfavorable opinions of the
ACA has narrowed to the closest margin in over 2
years, with 43% saying they have a favorable view of
the law and 41% saying they have an unfavorable
view. These percentages in July of 2014 were 53%
unfavorable and 37% favorable. When those who say
they view the ACA favorably are asked to say why in
their own words, the most commonly mentioned
reason is that it will expand access to health care and
health insurance (61%). When those with an unfa-
vorable view are asked the same question, the most
commonly mentioned reasons are ﬁnancial consid-
erations, including concerns that health insuranceand healthcare costs are increasing. Consistent with
previous Kaiser polls, the majority of the public (57%)
said that the health reform law has had no direct
impact on their families. If they do cite an impact,
almost equal shares report that the law has helped
them (19%) or the law has hurt them (22%). Of those
who would like to see the law repealed, 11% are
Democrats, 30% are Independents, and 57% are Re-
publicans (28) (Figure 13).
CONGRESSIONAL BUDGET OFFICE (CBO) REVISES
DOWNWARD HEALTH REFORM COSTS. In March
2010, the CBO projected that the insurance-related
provisions of the ACA would cost the federal gov-
ernment $710 billion from ﬁscal year 2015 through
ﬁscal year 2019. The most recent projections, in
March 2015, indicate that the cost will be $506 billion
for that same time period, a reduction of 29% (29).
CMS OUTLINES AREAS OF IMPACT UNDER THE
ACA. A January 2015 report from CMS detailed the
impact of the ACA on patient safety, reduction in
hospital readmissions, integration of care, physician
and hospital reporting, and increases in the use of
electronic health records (EHRs) (30). Speciﬁc areas
of impact cited by CMS included:
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D16Increases in Patient Safety
The Partnership for Patients, funded by the
ACA, includes 26 hospital engagement net-
works representing 80% of the American pop-
ulation. An HHS report on the program as of
December 2014 showed an estimated 50,000
fewer patients died in hospitals and approxi-
mately $12 billion in healthcare costs were
saved as a result of a reduction in hospital ac-
quired conditions from 2010 to 2013, trans-
lating into a 17% decline over the 3-year period.
Reduction in Hospital Readmissions
In 2012, CMS implemented an ACA program that
ties some Medicare penalties for hospitals to
30-day readmission rates for certain conditions.
After holding constant at 19% from 2007 to 2011
and decreasing to 18.5% in 2012, the Medicare
all-cause readmission rate has further decreased
to approximately 17.5% in 2013. This translates
into a reduction of 8% in the rate represent-
ing an estimated 150,000 fewer hospital
readmissions among Medicare beneﬁciaries
between January 2012 and December 2013.
Coordination of Care
Under 2015 rule-making, the Medicare Fee
Schedule will include a new chronic care man-
agement fee beginning next year. This separate
payment for chronic care management will sup-
port physician practices in efforts to coordinate
care for Medicare beneﬁciaries with multiple
chronic conditions. In addition, 12 states have
entered into agreements with CMS to integrate
care for Medicare-Medicaid dual enrollees.
Consumer Information
Websites created by the ACA provide information
to consumers about hospitals and healthcare pro-
fessionals. Hospital Compare has information
about the quality of care at over 4,000 Medicare-
certiﬁed hospitals and includes measures such as
access to timely and effective care, readmissions,
and the incidence of hospital-acquired conditions.
In FY 2015, hospitals with high rates of hospital-
acquired conditions will see their Medicare
payments reduced. Physician Compare provides
general information forup to3grouppractices.This
information includes names, addresses, and dis-
tance from the search location specialty, Medicare
assignment, and afﬁliated healthcare pro-
fessionals.Theﬁrst qualitymeasureswereaddedto
Physician Compare in 2014, and since then the
number of groups reporting data through the PQRS
has doubled. In 2015, CMS plans to expandPhysician Compare to include quality information
results for all physician groups.
Electronic Health Records
Adoption of EHRs continued to increase among
physicians, hospitals, and others serving
Medicare and Medicaid beneﬁciaries. The pro-
portion of U.S. physicians now using any kind
of EHR increased from 18% to 78% between
2001 and 2013, and 94% of hospitals now report
use of certiﬁed EHRs.
ACA SURVIVES SUPREME COURT CHALLENGE. On
June 24, 2015, the Supreme Court ruled 6 to 3 to
uphold a key part of the ACA that provides health
insurance subsidies to all qualifying Americans. The
ruling was in the case of King v. Burwell, which
challenged the availability of the ACA’s premium
subsidies in states with a federally run Marketplace—
including states with a federally facilitated Market-
place (FFM) or a State Partnership Marketplace (SPM).
The case did not challenge premium subsidies in
states with a state-run Marketplace.
The King v. Burwell petitioners challenged the
legality of the IRS regulation allowing premium sub-
sidies in states with an FFM as contrary to the lan-
guage of the ACA that stated that subsidies were only
available to “an exchange established by the state.”
The Supreme Court majority concluded that the
disputed phrase is ambiguous when read in context,
and therefore does not have to be interpreted liter-
ally. Chief Justice Roberts wrote “Congress passed the
Affordable Care Act to improve health insurance
markets, not to destroy them. If at all possible we
must interpret the Act in a way that is consistent with
the former, and avoids the latter.” Justices Kennedy,
Bader Ginsburg, Breyer, Sotomayor, and Kagen joined
Roberts in the majority. Opposing the decision were
Justices Scalia, Thomas, and Alito Jr.
The Supreme Court’s decision about the availabil-
ity of premium subsidies in states with an FFM has
signiﬁcantly affected the number of people who have
access to subsidies. If the IRS rule had been over-
turned by the Supreme Court, people in the 27 states
relying on an FFM and the 7 states with an SPM would
have lost access to subsidies, affecting an estimated
12.5 million people (30) (Figure 14).
CVD COST AND REIMBURSEMENT
CVD AND HEALTHCARE EXPENDITURES. The eco-
nomic costs of CVD and stroke in the United States
have never been higher. CVD is the nation’s single
most costly diagnostic group, with a total economic
cost of $320.1 billion in 2011. This total includes $195.6
FIGURE 14 State Health Insurance Marketplace Types, 2015
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D17billion in direct costs (hospital services, physicians
and other professionals, prescribed medications,
home health care, and other medical durables) and
$124.5 billion in indirect costs, including lost future
productivity (cardiovascular and stroke premature
deaths). By comparison, the estimated cost of all
cancer and benign neoplasms was $216 billion ($86
billion in direct costs and $130 billion in indirect
costs). The projected total cost of CVD is expected to
rise from $656 billion in 2015 to more than $1.2 trillion
in 2030 (31) (Figures 15 to 17).
SPOTLIGHT ON VARIATION IN CHARGES FOR
CARDIOVASCULAR PROCEDURES. The New York
Times, in a feature titled “The Odd Math of Medical
Tests: One Scan, Two Prices, Both High,” focuses on
the case of Len Charlap, who had 2 outpatient
echocardiograms in the past 3 years. The ﬁrst, per-
formed by a technician in a community hospital in
central New Jersey, lasted <30 min. The next, at a
premier academic medical center in Boston, took 3
times as long and involved a cardiologist. When Mr.
Charlap received the charges, the numbers seemed
backward; the community hospital had chargedapproximately $5,500, and the teaching hospital
billed approximately $1,400 for the much more
elaborate test.
The article, part of a larger series on medical
testing, focused on the wide variety in pricing for
echocardiograms and the failure of prices to fall even
though the costs for testing machines have dropped
considerably. Dr. David Weiner, the chairman of
the advocacy committee of the American Society of
Echocardiography (ACE), acknowledged the wide
price disparities, but said they were aligned with
other health services and procedures and attributed
the variation to multiple factors, including the need
to subsidize poorly reimbursed services. The article
points out that the major medical societies, including
ACE and the ACC, have developed guidelines for the
appropriate use of the test.
The Times article notes that in some other coun-
tries, regulators set what are determined to be fair
charges that include a built-in proﬁt ($80 in Belgium,
$115 in Germany, and from $50 to $80 in Japan). On
the other hand, the article also notes that in the
United States, Medicare only pays in the hundreds for
FIGURE 15 Direct and Indirect Costs of CVD and Stroke
(in Billions of Dollars), United States, 2011
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This ﬁgure details the total direct and indirect costs related to
CVD in the United States in 2011. Figures are stated in billions of
dollars. Abbreviation: CVD ¼ cardiovascular disease. Source:
Mozafarian, Danush, et al. “Heart Disease and Stroke Statistics—
2015 Update: a Report from the American Heart Association.”
Circulation (2015); 131(4):e 29-32. Web. 3 May 2015.
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D18the procedure and that the vast majority of patients
(and their insurers) pay less than the listed prices.
The article concludes with information about the
newest miniature echocardiogram machines, whichFIGURE 16 Projected Total Costs of CVD, 2015 to 2030 (2012 $ in B
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heart failure; CVD ¼ cardiovascular disease; HBP ¼ high blood pressure
tistics—2015 Update: a Report from the American Heart Association.” Cisell for well under $10,000 and are widely being used
in other countries and at some pilot programs in U.S.
medical schools. The article quotes Dr. Erick J. Topol,
a cardiologist at Scripps Health in San Diego who
studies echocardiography: “It brings $350,000 imag-
ing technology to the bedside as a screening test, at
almost no cost. but it is not being embraced because
of our model of payment” (32).
William A. Zoghbi, MD, MACC, past president of
the ACC, responding to the Times article in a blog
post, countered that the article focuses so much on
charges that it loses sight of echocardiography as
a valuable front-line tool for the diagnosis and
management of CVD. Zoghbi also refers to the
development of appropriate use criteria and ACC’s
participation in Choosing Wisely, a patient-focused
initiative by the American Board of Internal Medi-
cine Foundation that highlights tests and procedures
that patients and providers should question. The
ACC’s Choosing Wisely list includes several items
involving appropriate use of imaging tests, including
echocardiography (33).
Wide variation of cardiovascular charges is
also explored in a 2014 cross-sectional analysis in
charges and prices across California for percutaneous
coronary intervention with a drug-eluting stent
and without major complications (MS-DRG-247).
Adjusted charges for the average California patient
admitted for uncomplicated percutaneous coronaryillions) in the United States
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FIGURE 17 Projected Direct Costs of Total Cardiovascular Disease by Type of Cost (2010 $ in Billions)
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This ﬁgure details the direct costs of total cardiovascular disease from 2012 to 2030 in 2010 dollars in billions. Graphs include subcategories
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Mozafarian, Danush, et al. “Heart Disease and Stroke Statistics—2015 Update: a Report from the American Heart Association.” Circulation
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D19intervention ranged from $22,047 to $165,385 (me-
dian: $88,350), depending on which hospital the pa-
tient visited. Hospitals in areas with the highest cost
of living, those in rural areas, and those with more
Medicare patients had higher charges, while
government-owned hospitals charged less. Overall,
the study’s model explained 43% of the variation
in adjusted charges. Estimated discount prices paid
by private insurers ranged from $3,421 to $80,903
(median: $28,571) (34).
CARDIOLOGIST COMPENSATION. After years of
steady increases, cardiology compensation overall
dropped by nearly 8% from 2012 to 2013, according
to the 2014 Medaxiom Provider Compensation and
Productivity Report. Between 2010 and 2012, the
overall median compensation rose from $456,110
to $548,587. In 2013, compensation fell to $505,266.
Median compensation per relative value unit re-
mained the same in 2012 and 2013 at $54.
Most cardiologists overall saw decreases, but the
losses were not felt equally. Physicians who worked
in an integrated model received more compensation
than physicians in a private practice setting. Overall
median compensation for integrated cardiologists
was $548,630 compared with $424,380 for cliniciansin private practice. Private practice experienced a
more signiﬁcant decline in compensation per full-
time cardiologist, slipping 8.9% compared with
6.9% for those in an integrated model.
Despite a drop of $27,000, interventional cardiol-
ogists in the integrated model continue to be the
top earners among all cardiologists, with a median
compensation of $558,824. Electrophysiologists, by
comparison, earned $525,664, invasive cardiologists
received $504,398, and general cardiologists earned
$454,837.
Physicians in the Midwest fared best for compen-
sation despite a 5.8% drop, with a median of
$559,829. The Northeast had the steepest drop at 10%
and the lowest pay at $466,235. Compensation in
the South dropped 4.5% to $525,496 (35). Other
compensation studies for the cardiologist population
show different absolute values though the trends are
similar.
MEDICARE ACCESS AND CHIP REAUTHORIZATION
ACT. On April 16, 2015, President Obama signed into
law the Medicare Access and CHIP Reauthorization
Act of 2015 (MACRA) that permanently repeals the
SGR formula (see the Emerging Payment Reform
section for announcement). The new law affects a
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D20broad range of stakeholders, including cardiologists.
In addition to the repeal of the SGR, the law:
 Establishes a period of positive payment increases
by providing annual 0.5% increases for clinicians
beginning July 1, 2015, and ending December 31,
2018, in order to support a smooth and predictable
transition from fee-for-service to quality-based
payments.
 Beginning in 2019, provides for 2 new payment
pathways for clinicians: the new Merit-Based
Incentive Payment System (MIPS) or an Alterna-
tive Payment Model (APM).
MIPS . Eligible clinicians who elect to participate in
MIPS will receive yearly payment increases or de-
creases based on their performance. Beginning in
2019, MACRA replaces the existing quality reporting
programs of PQRS, Meaningful Use (MU), and the
Value-Based Payment Modiﬁer (VM) with the MIPS.
Instead of having 3 reporting systems with 3 separate
reporting deadlines, there will be 1 system.
Under the new law, each clinician will receive a
composite score (of 0 to 100) based primarily on 4
categories—clinical quality, meaningful use, resource
use, and clinical practice improvement. These 4 cat-
egories will use quality measures already in place
under the existing Medicare quality reporting pro-
grams, and additional measures will be deﬁned and
further developed. The clinical practice improvement
category will recognize clinicians for activities that
contribute to the advancement of patient care, safety,
and care coordination, such as registry participation
and tele-health services.
Performance will be assessed against benchmark
composites issued to clinicians at the beginning of a
performance year, based on the previous year’s per-
formance. Clinicians with the highest MIPS composite
could earn additional payments. Those clinicians
receiving a score below the threshold will receive a
reduced payment. Maximum bonus payments will
begin at 4% in 2019 and gradually increase to 9% in
2022 and beyond. The maximum payment penalty
will start at 4% in 2019 and gradually increase to 9%
in 2022 and beyond. The total amount of penalties
under the new system is less than the combined total
amount of penalties under the previous reporting
programs.
APM. The new law incentivizes participation in
Medicare and private payer APMs. Clinicians who opt
to participate in an APM and receive at least 25% of
their Medicare revenue through an APM beginning in
2018 will receive a 5% payment bonus. The threshold
for receiving APM bonuses will increase over time.
The new law recognizes that the administrative andﬁnancial responsibilities of participation in an APM
have been a barrier to small practices, and $20 million
annually has been allocated to assist APM participa-
tion by practices of 15 or fewer and practices serving
rural and underserved areas (36).
ACC/AHA TOASSESS VALUE IN PRACTICE GUIDELINES
AND PERFORMANCE MEASURES. On March 27, 2015,
citing accelerating healthcare costs and ﬁnite re-
sources, the ACC and the AHA announced they would
begin building value assessments into their clinical
documents. Historically, the societies have only con-
sidered clinical efﬁcacy and outcomes when drafting
clinical documents. Now, a proposed level of value
will be added with categories that include “high
value,” “intermediate value,” “low value,” “uncertain
value,” and “value not assessed.” The level of value
will be accompanied by a level of value evidence
ranking (A, B, C) that shows the type of information
used to make the value decision.
To determine the level of value, the societies propose
using the “quality-adjusted life year” (QALY), a stan-
dard outcomes measure in economic evaluation. They
further propose using the WHO’s cost-effectiveness
benchmark—3 times a country’s gross domestic prod-
uct (GDP) per capita—as an upper threshold. Using these
benchmarks in the U.S. system, treatments that have a
cost-effectiveness ratio of $150,000/QALY or more
would be considered low value.
The societies acknowledge the challenges associ-
ated with determining value assessments, including
the fact that treatment costs vary over time and
location. There is no national consensus as to how
cost should inﬂuence treatment decisions and only a
limited number of cost-effectiveness studies exist to
provide an evidence base (37).
CVD RESEARCH. Despite the costs and burden of
CVDs and the signiﬁcant return on investment in
National Institutes of Health (NIH) research in help-
ing to reduce morbidity and mortality related to these
conditions, NIH only invests a highly dispropor-
tionate 7% of its budget on CVD research (38)
(Figure 18).
CURRENT AND EMERGING WORKFORCE
GLOBAL WORKFORCE SHORTAGE PREDICTED. Accord-
ing to the most recent report from the WHO, the
world will be short some 12.9 million healthcare
workers by the year 2036, posing possible serious
implications for the health of billions across all re-
gions of the world. The shortage ﬁgure stands at 7.2
million currently. The report, “A Universal Truth: No
Health Without a Workforce,” identiﬁes a number of
key causes for a shortage. These include an aging
FIGURE 18 Heart Disease, Stroke, and Other CVD Research
Funding as a Percent of Total NIH Funding: FY 2014
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This ﬁgure breaks down the funding from the NIH in ﬁscal year
2014 by funding for heart disease (blue), stroke (orange), other
CVD (red), and all other research areas (grey). Abbreviations:
CVD ¼ cardiovascular disease; FY ¼ ﬁscal year; NIH ¼ National
Institutes of Health. Source: “Breaking Our Hearts: Still America’s
No. 1 Killer: NIH Funding for Heart and Stroke Research.” Heart.org.
American Heart Association, n.d. Web, 3 May 2015.
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D21workforce, not enough young people entering the
profession, a growing world population with signiﬁ-
cant increases in noncommunicable diseases such as
CVD, and internal and international migration of
healthcare workers. The report does include some
encouraging developments, such as more countries
moving toward a basic threshold of 23 skilled health
professionals for every 10,000 people, although there
still are 83 countries below that threshold. The report
makes recommendations for actions to lessen the
projected shortage, including:
 Increased political and technical leadership that
will support long-term human resources develop-
ment in healthcare;
 Collection of reliable data and strengthening
health databases and registries;
 Maximizing the role of mid-level and community
health workers to make front-line health services
more accessible (39).
POSSIBLE U.S. SHORTAGES OF HEALTHCARE WORKERS
LESS EASY TOPREDICT. Healthcare is possibly the most
complicated industry in the United States, and, as
such, it is difﬁcult to predict changes in supply and
demand for the country as a whole and for more thanseveral years in the future. For example, Figure 19, a
2013 analysis from the Association of American
Medical Colleges (AAMC) of physicians per 100,000 in
the population shows how only 1 factor, geography,
may play a signiﬁcant role in whether a market is
over-or understaffed with physicians.
SOME INCREASES IN U.S. HEALTHCARE WORKER
SUPPLY ARE PREDICTED. Predictions for a modest
increase in the supply of U.S. healthcare professionals
(without accounting for demand) can be found in a
2014 report from the Health Resources and Services
Administration within the HHS. This report predicts
the supply of physicians in all nonprimary care ﬁelds
will grow by 21% between 2010 and 2025. The per-
capita supply of physicians, however, is expected to
vary, with per-capita declines projected in the ﬁelds
of cardiology, psychiatry, and general surgery, and
per-capita growth projected within the pediatric
subspecialties and in obstetrics-gynecology. The
report also predicts the supply of nonprimary care
advanced practice nurses to grow more rapidly (141%
over the period) than physicians, and the supply of
nonprimary care physician assistants (PAs) to grow
more rapidly (more than double over the period) than
physicians but less than advanced practice nurses
(40). The corresponding increase in supply for pri-
mary care physicians during the same period is ex-
pected to be at 8% (41).
AAMC PREDICTS U.S. DEMAND TO EXCEED SUPPLY.
AAMC, for its part, does predict overall shortages of
U.S. physicians in a March 2015 study. To reﬂect
future uncertainties from a variety of variables, the
study presents ranges for its projected shortage of
physicians, rather than speciﬁc numbers. The study
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D22predicts demand for physicians in this country to
grow faster than supply. Although it predicts physi-
cian supply will grow modestly between 2013 and
2025, it says demand will grow more steeply, with
demand exceeding supply by a range of 46,000 to
90,000 physicians. These predicted shortages in 2025
will vary by specialty grouping, including a shortfall
of between 12,500 and 31,100 primary care physicians
and a shortfall of between 28,200 and 63,700 non-
primary care physicians. AAMC predicts these short-
ages under every modeled scenario, including
increased use of advanced practice nurses; greater
use of alternate settings such as retail clinics; delayed
physician retirement; and rapid changes in payment
and delivery. AAMC points to a rapidly expanding
Medicare population and limits on support for
physician training as signiﬁcant factors driving the
projected shortage (42).
RAPID CHANGES IN CARDIOLOGY LANDSCAPE. In a
President’s Page article in JACC, then-ACC president
Patrick T. O’Gara detailed how rapidly the landscape
of cardiology had changed in less than a decade. He
recalled a 2009 ACC workforce survey that predicted
signiﬁcant shortages of cardiovascular specialists and
called for a rapid increase in supply. Just a year later,
the global economy took a turn for the worse and
massive Medicare expense cuts for cardiovascular
services led to a surge in the number of physician
practices integrating with hospitals and other large
healthcare systems. More recently, O’Gara points out,
the transition of the healthcare system to a focus on
value rather than volume, Medicare’s efforts to
bundle payments, increasingly high deductibles in
tiered health plans, and a decline in cardiovascular
tests and procedures has resulted in a “relativeFIGURE 20 New Patients per Full-Time Cardiologist From 2004 Thr
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pecially in prime geographic locations” (43).
In an interview in CardioSource WorldNews: Focus
on Fellows in Training and Early Career Cardiologists,
Zachary M. Gertz, MD, Director of Structural Heart
Disease at Virginia Commonwealth University, noted
that it is a very competitive market for incoming
cardiovascular professionals interested in structural
heart disease, valve disease, advanced electrophysi-
ology, and other procedure-intensive areas. He did
note, however, that general cardiology and heart
failure opportunities are looking more plentiful (44).
CHANGES IN CARDIOLOGY TESTING AND PROCEDURE
UTILIZATION. Cardiology groups across the country
have reported a decrease in utilization patterns for
many of the historically high-volume diagnostic tests
and cardiac procedures. In fact, according to Medax-
iom’s 2014 annual survey (2013 data), the number of
new patients entering into a cardiology practice on a
per-cardiologist basis—perhaps the strongest indica-
tor of future testing and procedure volumes—is at a
10-year low (45) (Figure 20).
MEDICAL SCHOOL ENROLLMENT. In 2006, as a
response to concerns of a future U.S. physician
shortage, the AAMC recommended a 30% increase in
the U.S. medical school enrollment by 2015. The
AAMC recommended meeting this goal by increasing
enrollment at existing medical schools and, where
appropriate, creating new medical schools. Results of
the AAMC 2014 Medical School Enrollment Survey
shows that an increase of 30% in ﬁrst-year enrollment
has almost been attained. The survey results suggest
that ﬁrst-year medical enrollment from 2019 to 2020
will reach 21,304, a 29.2% increase over the 2002 to
2003 levels used as a baseline (Figure 21).ough 2013
2009 2010 2011 2012 2013
607
565 566
521
507
from 2004 through 2013. Source: Medaxiom, 2015.
FIGURE 21 Projected First-Year Enrollment Growth in U.S. Medical Schools
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This ﬁgure details the shows the projected ﬁrst-year enrollment growth in U.S. medical schools from 2002 through 2025. Data for 2002 through 2014 is
historical data, data for 2014 through 2019 is survey data, and 2019 through 2025 is projected data. Categories include original schools (blue), current
schools (orange), and an organizational target of 30% over 2002 enrollment (grey line). Source: American Association of Medical Colleges, 2015.
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D23Other key ﬁndings from the survey include in-
creases in the number of schools reporting concerns
about their number of clinical training sites (an in-
crease of 26% in concerns reported from 2010 to 2014)
and concerns about enrollment growth outpacing
growth in graduate medical education (GME)
(Figure 22). Many schools are continuing to develop
and implement initiatives to increase student interest
in primary care, and enrollment increases at D.O.-
granting schools continues to accelerate (46).
IOM REPORT RECOMMENDS BETTER ALIGNING OF
GME FUNDING WITH WORKFORCE NEEDS. In 2012,
the Institute of Medicine (IOM) began to conduct an
independent review of the governance and ﬁnancing
of the nation’s GME system. Their report in 2014,
Graduate Medical Education That Meets the Nation’s
Health Needs, recommends signiﬁcant changes to the
GME system to address current deﬁciencies and bet-
ter shape the physician workforce for the future. The
report reiterates that the vast majority of public
ﬁnancing for GME comes from the Medicare program,
but notes that the statutes and regulations governing
GME ﬁnancing date from 1965, a time when hospitals
were the central, if not exclusive, site for physician
training. The report says although hospital services
remain essential, the burden of chronic disease, the
increased emphasis on prevention, and modern
technologies means that, increasingly, health care
takes place in community and outpatient settings.
Yet, as the report notes, the GME payment system
discourages physician training outside the hospital,where much of health care is delivered (47). The IOM
recommendations, which would require legislative
changes, include:
 Maintaining total federal GME funding at the cur-
rent level for the next decade, with the core of
funding remaining with Medicare to ensure sta-
bility as the nation transitions to a recommended
new system of payment policy;
 Ending the current system of basing GME pay-
ments on Medicare inpatient days, the resident-
to-bed ratio, and other factors. The Report
recommends an easier to understand basic per-
resident amount for each resident, with geographic
adjustments;
 Elimination of the current separate funding
streams for direct GME expenditures and indirect
costs. The total available funds would be divided
into an operational fund to support existing GME
programs and a new GME transformation fund to
support innovation, as well as new GME programs
in needed specialties and underserved areas.
 Directing funds to the institutions that are respon-
sible for the actual educational content of GME—
the GME sponsors (such as educational institutions,
community health centers, or GME consortia)—
rather than just to teaching hospitals (48).
ACC REACTS TO IOM REPORT. The ACC, in providing
requested feedback to Congress regarding GME, says
the IOM report is “an important effort to move the
conversation forward, but does little to address the
FIGURE 22 Percentage of Schools Showing Concern About GME, 2012 to 2014
35%
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This ﬁgure shows the percentage of schools showing concern about GME from 2012 through 2014. Categories include concern for my incoming
students, concern in my state, and concern nationally, with major concern (dark blue) and moderate concern (light blue) broken out. GME ¼
graduate medical education. Source: American Association of Medical Colleges, 2015.
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D24projected shortfall in the medical workforce.” The
ACC, in its letter to Congress, said it supports the
AAMC’s overarching workforce policy recommenda-
tions, which include:
 Increasing the number of federally supported GME
training positions by at least 4,000 new positions a
year to meet the needs of a growing, aging popu-
lation and to accommodate the additional gradu-
ates from accredited medical schools.
 Continuing federal investment in delivery system
research and evidence-based innovations in health-
care delivery.
 Educating lawmakers about the need to not only
expand support for GME, but also leverage clinical
reimbursement and other mechanisms to achieve
geographic distribution of physicians and inﬂuence
specialty composition.
 Targeting funding for new residency positions
based on population growth, regional and state-
speciﬁc needs, and evolving changes in delivery
systems (49).
TRENDS IN HIRING AND TRAINING NEW AND
EMERGING HEALTHCARE POSITIONS. A 2014 survey
of human resources and clinical operational leaders
in hospitals and health systems provided informa-
tion about changes in the healthcare workforce. The
survey was distributed via e-mail with a link to an
online survey tool and received responses from 323
clinical and human resources leaders from healthcare
organizations in the United States. Key ﬁndings
include:
 Some 86% of survey respondents say they are
aware of a growing need for new types of health-
care workers; Survey response on planning for new roles was
strongest for ICD-10 coders, a position critical to
proper documentation and reimbursement for the
mandated change from ICD-9 to ICD-10. Forty-four
percent of respondents say they are currently
recruiting or planning to recruit for this position.
 Care Coordinator, a key position for improving
patient satisfaction and care quality, ranked as the
second most sought-after new position. Forty-one
percent of respondents are currently recruiting or
planning to recruit for Care Coordinators.
 Expanding the need for tele-health services was
clearly reﬂected, with nearly one-quarter of res-
pondents recruiting or planning to recruit tele-health–
trained physicians and 21% seeking or planning to
seek tele-health–trained registered nurses.
 Reasons given by respondents as to why the
new roles are important include improving patient-
care quality, reducing errors and readmissions,
improving patient satisfaction, and accommoda-
ting new reimbursement structures that incen-
tivize value-based care (50).
TEAM-BASED CARE
INCREASING COMPLEXITY OF HEALTHCARE DRIVES
NEED FOR HIGH-FUNCTIONING TEAMS. In the
introduction to the IOM discussion paper “Core
Principals & Values of Effective Team-Based Care,”
the authors say that a team-based approach to
healthcare in the United States is being driven by
exponential increases in the complexity of medicine,
with nearly 3,000 clinical practice guidelines and
more than 25,000 new clinical trials published each
year. The paper goes on to point out that team-based
care gained momentum with the passage of the ACA
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D25and other national initiatives as well as many “deeply
considered, well-executed initiatives in team-based
care in pockets across the United States.” The paper
also points out factors restraining the adoption of
team-based care including lack of experience and
expertise, cultural silos, deﬁcient infrastructure,
and inadequate or absent reimbursement (51).
The IOM itself gave support to team-based care in
its 2011 report “The Future of Nursing: Leading
Change, Advancing Health” with the assertion that
“advanced practice registered nurses should be able
to practice to the fullest extent of their education
and training” (52).
This section will include references to Advanced
Practice Providers (APPs), which include advanced
practice registered nurses (APRNs), PAs, and phar-
macists (PharmDs). APPs have the requisite educa-
tion, training, and experience to allow them greater
autonomy. The high value of other team members
(including registered nurses, licensed practical
nurses, medical assistants, nurse aides, technologists,
nutritionists, genetic counselors, social workers, and
chaplains) should also be recognized (53).
SCOPE OF PRACTICE ISSUE DRAWS DIFFERING
VIEWS. While, in general, team-based care draws
much support in the medical community, there are
questions about the levels of independence for
nonphysician practitioners and the need for physi-
cian supervision. These questions lead to licensing
differences at the state level, policy differences at the
national level, and viewpoint differences at the
practice level.
The American Medical Association (AMA), at its
annual meeting in 2014, adopted a policy to deﬁne
physician-led, team-based health care as “the
consistent use by a physician of the leadership
knowledge necessary to identify, engage and elicit
from each team member the unique set of training,
experience and qualiﬁcations needed to help patients
achieve their goals, and to supervise the application
of those skills.” AMA restated its belief that the ulti-
mate responsibility of care rests with the physician
and advocated that physicians maintain authority for
care in any team arrangement to ensure patient safety
and quality (54).
The Federal Trade Commission (FTC), on the other
hand, has consistently urged state legislatures to
avoid imposing restrictions on the scope of practice of
advanced practice nurses, unless those restrictions
are necessary to address well-founded patient safety
concerns. The FTC states that because APRNs and
other practitioners, including physicians, may be
trained and licensed to provide many of the samehealthcare services, scope of practice restrictions can
limit the supply of those primary healthcare services.
The FTC goes on to say that “new or extended layers
of mandatory physician supervision may not be
justiﬁed” (55).
A 2013 study published in the New England Journal
of Medicine highlights the differences of opinion be-
tween primary care physicians and nurse practi-
tioners in primary care. The survey of 467 nurse
practitioners and 505 physicians found both groups
agree that nurse practitioners should practice “to the
full extent of their education and training.” However,
only 17% of physicians agreed that nurse practitioners
should coordinate a patient’s care as a leader of a
“medical home” versus more than 82% of the nurse
practitioners, and only 3.8% of doctors felt that a
nurse practitioner should be paid the same for
providing the same service as a physician, compared
with 64% of the nurse practitioners (56).
A 2014 ACC survey of its Board of Governors also
sheds light on the issue of physician leadership and
practice independence for advanced practice nurses.
Almost all survey respondents (92%) support incor-
porating advanced practice nurses into clinical prac-
tice and most of this support is strong (80%).
However, almost three-quarters (72%) oppose the
independent practice of advanced practice nurses
without physician supervision, with over one-half
voicing strong opposition (57).
SCOPE OF PRACTICE VARIES BY STATE. Only
approximately one-third of the nation has adopted
full practice authority licensure and practice laws for
advanced practice nurses. Figure 23, from the Amer-
ican Association of Nurse Practitioners, shows the
2015 nurse practitioner state practice environment.
ACC MEMBERSHIP SHOWS EVOLUTION OF TEAM-
BASED CARE. The College formally reached out to
nonphysician members of the cardiac care team in
2003, when it approved a new cardiac care associate
membership category for cardiovascular registered
nurses (RNs), clinical nurse specialists, nurse practi-
tioners, and PAs. Soon after, the Nursing Education
Work Group was established, and the ACC was
awarded a Certiﬁcate of Accreditation as a provider of
continuing nursing education from the American
Nurses Credentialing Center. In 2007, cardiac care
associate membership was extended to clinical car-
diovascular PharmDs. In 2009, the ACC approved the
designation of Associate of the American College of
Cardiology (AACC) for licensed APPs with board cer-
tiﬁcation in their respective disciplines, at least 5
years of experience in a clinical area of expertise
within cardiology, at least 2 years of ACC membership,
FIGURE 23 Nurse Practitioner State Environment
Full Practice
Reduced Practice
Restricted Practice
State practice and licensure law provides for nurse practitioners to evaluate patients, diagnose,
order and interpret diagnostic tests, initiate and manage treatments—including prescribing
medications—under the exclusive licensure authority of the state board of nursing. This is the
model recommended by the Institute of Medicine and National Council of State Boards of
Nursing.
State practice and licensure law reduces the ability of nurse practitioners to engage in at least
one element of NP practice. State requires a regulated collaborative agreement with an outside
health discipline in order for the NP to provide patient care.
State practice and licensure law restricts the ability of a nurse practitioner to engage in at least
one element of NP practice. State requires supervision, delegation, or team–management by an
outside health discipline in order for the NP to provide patient care.
This U.S. map details the regulatory environment for nurse practitioners as it relates to scope of practice. States are divided into full practice
(green), reduced practice (yellow), and restricted practice (red). NP ¼ nurse practitioner. Source: American Association of Nurse Practitioners.
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D26and upon review of 3 formal letters of recommen-
dation from current FACCs or AACCs. The ACC also
approved the awarding of the title of FACC to APPs
with exceptional academic achievement. ACC bylaws
were amended to allow APPs to be eligible for Board
membership, and in 2010 an APP was added to the
Board of Trustees, the ﬁrst nonphysician member of
the Board. Currently, the College has over 4,600 car-
diac care associate members, reﬂecting an enduring
commitment to the concept of cardiovascular team-
based care (58).
ACC PRACTICE CENSUS SHOWS ADVANTAGES OF
AND OBSTACLES TO TEAM-BASED CARE. To better
understand the changing practice landscape and
evolution of team-based care, the ACC conducted
a large survey of cardiovascular practices in 2010.Over 2,400 unique practices in the United States
participated in this research, representing almost
14,000 cardiologists.
Four-in-seven (57%) reported that their approach
to care delivery was “team-based,” using nonphysi-
cian practitioners and clinical staff to participate in
the decision making, coordination of care, and shared
responsibility for the quality of care. Solo practi-
tioners were less likely to employ a team-based care
model, while hospital-based, multi-specialty, and
academic practices were more likely to utilize physi-
cian extenders in their care delivery.
Those practices that had implemented team-based
care identiﬁed a number of improvements, includ-
ing: increased efﬁciency (63%), improved quality
of care (53%), and increased patient satisfaction
(50%). Other beneﬁts of the team approach included
J A C C V O L . 6 6 , N O . 1 9 , S U P P L D , 2 0 1 5 Laslett et al.
N O V E M B E R 1 0 , 2 0 1 5 : D 1 – 4 4 2015 ACC Environmental Scanning Report
D27increased staff satisfaction (36%) and improved
ﬁnancial outcomes (19%).
Although there seemed to be clear beneﬁts to
providing team-based care, many practices report
that they did not provide team-based care because of
no or minimal reimbursement (34%) and the inability
to break the more traditional view of practicing
medicine held by patients and providers (33%). Lack
of tools (18%) and no clear practice model (19%) were
also cited as hurdles to more utilization of physician
extenders.
The research also explored some of the team-based
care systems or functions established as part of the
provider infrastructure as well as the ways that
physician extenders are utilized. Team-based care
providers are most likely to implement patient edu-
cation (69%) and internal communications (63%) as a
part of their care protocols. These ﬁndings suggested
that while most cardiovascular providers are prac-
ticing team-based care, opportunities exist for more
interdisciplinary roles and responsibilities, increased
tools for feedback and quality improvement, and
increased responsibility for physician extenders (53).
JACC LOOKS AT THE MULTI-SPECIALTY APPROACH
OF THE HEART TEAM. The concept of a Heart Team
(different medical disciplines formally working
together) has become the subject of increasing inter-
est in treating CVD. A 2013 state-of-the-art paper in
JACC states that the rationale for team-based care is
to optimize the management of complex patient care
issues. These issues have been made ever more
difﬁcult as a result of the development of new devices
and approaches, increasing information from clinical
trials and large registries about novel strategies, and a
focus on patient groups at higher risk for adverse
outcomes because of age or comorbidities.
The Heart Team is especially useful in meeting a
central goal of patient-centric care: that the patient
and family be sufﬁciently educated about the alter-
natives available so that their expectations can be
met as fully as possible. Given the wide range of in-
formation available from different cardiovascular
specialties and the potential for individual physician
bias, Heart Teams have great potential merit. Indeed,
the Heart Team has emerged as a Class 1 indication in
both the 2010 European Society of Cardiology and the
European Association for Cardio-Thoracic Surgery
Guidelines for Coronary Revascularization, as well as
the 2012 ACC/AHA Guidelines for Coronary Artery
Bypass Grafting surgery. The Heart Team also is a
Class 1 indication for valvular heart disease inter-
vention per ACC/AHA valvular disease guidelines.
These teams offer a balanced approach to patient
care by emphasizing joint decision making amongdifferent medical care stakeholders such as cardiac
surgery and interventional cardiology. By exploring
multiple options available and discussing with pa-
tients and families when appropriate, a tailored
recommendation can be made to a more informed
and engaged patient. The paper states, “the Heart
Team approach is timely and has become mandatory
in light of evolving options in therapeutics, in the
resurgence of focus on patient-centered care, and for
optimizing delivery of care and its reimbursement
strategies” (59).
ACC CARDIOVASCULAR TEAM COUNCIL AND SECTION
LEADING A TRANSFORMATION IN CARE. In a May
2013 blog post in the ACC In-Touch Blog, members of
the ACC Cardiovascular Team Council and Section
outline the culture change and paradigm shift that is
required to make the cardiovascular team operation
more efﬁcient. The group says that “now is the time
to foster team-based cardiovascular care, given the
survival of practices will likely depend on how well
cardiology practices can adapt to the changes occur-
ring in health care.” Cardiovascular teams can be
comprised of a diverse group of skilled professionals
including physicians, nurses, nurse practitioners,
clinical nurse specialists, PAs, and PharmDs. The
group advocates for moving toward a culture where
team members encourage, educate, and collabo-
rate with each other. They say this will lead to
“passionate, knowledgeable care delivery, increased
patient satisfaction and an increase in the practice
capacity to deliver excellent care to a larger patient
base” (60).
ACC DEVELOPS HEALTH POLICY STATEMENT ON
TEAM-BASED CARE. In a pioneering policy state-
ment on cardiovascular team-based care in May of
2015, the ACC clariﬁed the College’s position on the
role of APPs within the cardiovascular care team. Key
points from the health policy statement are summa-
rized below.
 All cardiovascular APPs are taught problem-solving
algorithms, protocols for treatment, procedures,
and standards for general cardiovascular care. Some
APPs are taught to practice in a focused area of
cardiovascular care, such as heart failure. The tasks
of PAs can be modeled on the technical and clinical
tasks of the physicians, expanding the overall ca-
pacities of physician-led teams. PharmDsmay focus
on medication reconciliation during care transi-
tions, improving adherence, providing preventive
care, and managing complex drug regimens.
 Historically, the leader of a cardiovascular team
has been a cardiologist. It is the position of
the policy statement-writing group that team
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D28leadership should be ﬂexible, reﬂecting the speciﬁc
needs of a patient at a particular time and in a
particular setting. The leader should be the team
member with the greatest knowledge, experience,
and qualiﬁcations for the task at hand. For
example, a nurse or PharmD might lead a team
that organizes a chronic anticoagulation clinic.
 A useful motto for cardiovascular team care is
“shared goals and clear roles.” The team functions
most effectively when each member has a clear
understanding of his or her function and re-
sponsibilities and what is expected of him or her.
 Differences at the state level in regulations
deﬁning prescriptive authority among practi-
tioners can become a barrier to a broad-based
implementation of cardiovascular care teams, and
can create impediments to the development of
national standards for team-based care.
 Payment rules by Medicare and commercial payers,
and different standards for billing in inpatient and
outpatient settings, can also be a barrier to effec-
tive team-based care. In the ofﬁce, the APP can
provide services that give greater access to patients
and support greater practice income. In the hos-
pital, the APP does not submit a bill for a shared
visit, but the cost of the APP’s activity can be
justiﬁed by a gain in physician efﬁciency. Going
forward, cardiovascular team-based care will need
to successfully navigate a transition to new models
of payment.
 Some good examples of effective cardiovascular
team-based care include: chronic heart failure man-
agement; clinics for lipids, hypertension, and anti-
coagulation; exercise stress laboratories; arrhythmia
management of pacemakers and implantable
deﬁbrillators; and outreach to rural and remote
locations.
 Broad acceptance of cardiovascular team care par-
adigms can be realized by further educating the
cardiology community about their components,
characteristics, and potential to improve patient
outcomes (58).
KEY CARDIOVASCULAR STATISTICS
U.S. BURDEN OF DISEASE. Although the decline in
mortality rates for CVD in the United States is 60%
since the mid-1960s, CVD is still the overall leading
cause of death in this country. The risk factors remain
alarmingly high. CVD claims more lives than all forms
of cancer combined, with over 2,000 Americans dying
each day from these diseases—1 every 40 seconds.
From 2001 to 2011, death rates attributable to CVD
declined 30.8%. Yet in 2011, CVD still accounted for1 in every 3 deaths in the United States. The CVD
death rate that year was 229.6 per 100,000 Americans.
The death rates were 275.7 for males and 192.3 for
females. The rates were 271.9 for white males, 352.4
for black males, 188.1 for white females, and 248.6 for
black females.
Approximately 85.6 million Americans are living
with some form of CVD or the after-effects of stroke.
Nearly one-half of all African Americans age 20 and
older have some form of CVD: 48% of women and 46%
of men. Direct and indirect costs of CVD and stroke
total more than $320.1 billion. This total includes
health expenditures and lost productivity. The pro-
jected total cost of CVD is expected to rise from $656
billion in 2015 to more than $1.2 trillion in 2030 (61).
Figures 24 to 26 from the AHA detail incidence,
breakdown of deaths, and mortality trends (61).
CVD PREVENTION AND CARDIOVASCULAR HEALTH.
There has been an expanded focus in the United
States on CVD prevention and cardiovascular health
with an emphasis on healthy behaviors (diet, physical
activity, weight control, and not smoking) and health
factors (control of blood cholesterol, blood pressure,
and blood sugar). The AHA 2015 Statistical Update
offers details about these behaviors and health fac-
tors (61).
Smoking . Although there has been a substantial
decline in tobacco use in the United States, it remains
the second leading cause of total death and disability.
In adults, cigarette use declined from 24.1% in 1998 to
17.9% in 2013. Among high school students, the
decline was from 36.4% in 1997 to 15.7% in 2013. Still,
almost one-third of coronary heart disease deaths are
attributable to smoking and exposure to second-hand
smoke.
Phys i ca l act iv i ty . According to the 2013 National
Health Interview Survey, only one-half of American
adults meet the current goal of more than 150 min of
moderate aerobic physical activity or 75 min of
vigorous aerobic physical activity weekly. Women
(46.1%) were less likely to meet the goal than men
(54.2%). Between the National Health and Nutrition
Examination Survey (NHANES) 1988 to 1994 and
NHANES 2001 to 2006, the non–age-adjusted pro-
portion of adults who reported engaging in >12 in-
stances of physical activity per month declined from
57.0% to 43.3% in men and from 49.0% to 43.3% in
women. The AHA recommendation for overall car-
diovascular health is at least 30 min of moderate-
intensity aerobic activity at least 5 days per week
for a total of 150 min; or at least 25 min of vigorous
aerobic activity at least 3 days per week for a total
of 75 min; or a combination of moderate- and
vigorous-intensity aerobic activity and moderate- to
FIGURE 24 Incidence of Cardiovascular Disease (Coronary Heart Disease,
Heart Failure, Stroke, or Intermittent Claudication; Does Not Include Hypertension)
by Age and Sex
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This ﬁgure details the incidence of cardiovascular disease by age and sex. Incidence is
displayed per 1,000 person-years for men (blue) and women (orange) for age groups 45
to 54, 55 to 64, 65 to 74, 75 to 84, and 85 to 94. Source: Framingham Heart Study 1980
to 2003.
FIGURE 25 Percentage Breakdown of Deaths Attributable to Cardiovascular Disease
(United States, 2011)
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This ﬁgure shows deaths attributed to speciﬁc cardiovascular diseases in the United States
in 2011, including coronary heart disease 47.7% (blue), stroke 16.4% (purple), heart failure
7.4% (teal), high blood pressure 8.3% (red), diseases of the arteries 3.3% (grey),
and other 16.9% (orange). Source: American Heart Association.
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D29high-intensity, muscle-strengthening activity at least
2 days per week for additional health beneﬁts.
Diet and nutr i t ion . The leading risk factor for death
and disability in the United States is suboptimal diet
quality, speciﬁcally insufﬁcient intake of fruits, nuts/
seeds, whole grains, vegetables, and seafood, as well
as excess intake of sodium. Although more healthful
diets cost modestly more than unhealthful diets, the
difference is not always prohibitive. In a study
comparing 20 fruits and vegetables versus 20 com-
mon snack products, such as chips, cookies, pastries,
and crackers, the average price per portion of fruits
and vegetables was 31 cents, with an average of 57
calories per portion, compared with 33 cents and 183
calories per portion for snack foods.
Obes i ty . Although the overall prevalence of obesity
in U.S. youth was unchanged between 2003 to 2004
and 2011 to 2012, the prevalence did decrease among
those age 2 to 5 years. Obesity decreased among those
with higher socioeconomic status but increased
among those of lower socioeconomic status. The
overall prevalence of severe obesity in U.S. youth
(5.9%) continued to increase, especially among
adolescent boys.
In a report published in JAMA Internal Medicine,
researchers from Washington University School of
Medicine in St. Louis studied data from 2007 to 2012
of a nationally representative group of 15,208 people
ages 25 or older. The researchers estimate that during
that time period, 40% of men were overweight and
35% of men were obese. They estimate that 30% of
women were overweight and 37% were obese (62).
High blood pressure . Based on 2009 to 2012 data,
80 million U.S. adults have hypertension (32.6% of
adults over 20 years of age). African American adults
have among the highest prevalence of hypertension
in the world, with age-adjusted prevalence of hyper-
tension of 44.9% for men and 46.1% for women.
NHANES data from 2009 to 2012 revealed that among
U.S. adults with hypertension, 54.1% were controlled,
76.5% were currently treated, 82.7% were aware of
the condition, and 17.3% were undiagnosed. The
trend in the control of blood pressure has improved
among hypertensive adults, resulting in a higher
percentage with blood pressure at the optimal or
prehypertension level and a lower percentage in stage
1 and stage 2 hypertension.
High blood cholestero l and other l ip ids . A total
of 75.7% of children and 46.6% of adults have ideal
cholesterol levels. Prevalence of ideal levels has
improved over the past decade in children but
remained unchanged in adults. According to 2009 to
2012 NHANES data, more than 100 million U.S. adultsover 20 years of age have total cholesterol levels >200
mg/dl and almost 31 million have levels >240 mg/dl.
Diabetes mel l i tus . Diabetes affects 1 in 10 U.S.
adults, with 90% to 95% of cases being type 2. Dia-
betes disproportionately affects racial and ethnic
minorities. Type 2 diabetes, historically diagnosed
primarily in adults over 40 years of age, is becoming
increasingly common in children and adolescents.
The prevalence of type 2 diabetes in children and
adolescents has increased by 30.5% between 2001 and
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FIGURE 26 Cardiovascular Disease Mortality Trends for Males and Females
(United States, 1979 to 2011)
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This ﬁgure shows a comparison of cardiovascular disease mortality trends for males and
females in the United States from 1979 to 2011. Deaths in thousands are charted across the
speciﬁed time period for males (blue) and females (orange). Source: American Heart
Association.
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D302009, and it now constitutes one-half of all cases of
childhood diabetes.
GLOBAL BURDEN OF DISEASE. CVD is the leading
cause of death globally. An estimated 17.5 million27 Global Distribution of the Burden of Cardiovascular Diseases in Male
en (DALYs per 100,000)
114-2,137
2,138-3,314
3,315-4,228
4,229-10,772
Data not available
bal map shows the distribution of cardiovascular disease burden for men as
0 population. Ranges include 114 to 2,137 (green), 2,138 to 3,314 (yellow), 3
CVD ¼ cardiovascular disease; DALYs ¼ daily adjusted life years. Source: Wopeople died from CVD in 2012, representing 31% of all
deaths. Of these deaths, an estimated 7.4 million were
due to coronary heart disease and 6.7 million were due
to stroke. More than three-quarters of CVD deaths
occur in low- and middle-income countries. Figure 27
from the WHO shows the global burden of CVD in
men as measured in disability-adjusted life years (63).
WHO ACTION PLAN FOR NONCOMMUNICABLE
DISEASE (NCD). Under the leadership of the WHO, all
member states (194 countries) agreed in 2013 to reduce
the number of premature deaths from NCD by 25% by
2025 through 9 voluntary global targets. Two of the
global targets directly focus on preventing and con-
trolling CVD. The sixth target in the Global NDC action
plan calls for a 25% reduction in the global prevalence
of high blood pressure. The eighth target in the plan
states that at least 50% of eligible people should
receive drug therapy and counseling (including gly-
cemic control) to prevent heart attacks and strokes. In
2015, countries will begin to set national targets and
measure progress based on 2010 baseline data. In 2018,
the UN General Assembly will convene a third high-
level meeting on NCD to take stock of national prog-
ress in attaining the voluntary global targets (64).
DRIVERS OF GLOBAL CVD MORTALITY. A 2015 study
published in the New England Journal of Medicine
found that the aging and growth of the populations
measured in disability-adjusted life years with age standardized per
,315 to 4,228 (orange), 4,229 to 10,772 (red), and data not available
rld Health Organization.
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D31resulted in an increase in global cardiovascular
deaths by 41% between 1990 and 2013, despite a 39%
decrease in age-speciﬁc death rates in most regions.
The study, using data from the Global Burden of
Disease Study of 2013 (including data on 188 coun-
tries), found the increase in global cardiovascular
deaths was driven by a 55% increase in mortality due
to the aging of the populations and a 25% increase
due to population growth. The relative contributions
of these drivers were found to vary by region. Only in
Central Europe and Western Europe did the annual
number of deaths from CVD actually decline, sug-
gesting gains in cardiovascular health that were suf-
ﬁcient to overcome demographic forces. The authors
speculate that declines in cardiovascular deaths due
to epidemiologic change “are probably due to the
combined effect of birth cohorts’ decreased exposure
to tobacco smoking, improvements in diet, identiﬁ-
cation of cardio-metabolic risk factors, increased
focus on prevention and improved treatment of car-
diovascular disease” (65).
U.S. HEALTHCARE SYSTEM
COMMONWEALTH FUND UPDATE SHOWS U.S.
HEALTHCARE CONTINUES TO UNDERPERFORM. In a
2014 update of its multi-year comparison of health-
care systems in industrialized countries, The
Commonwealth Fund reports that while the United
States has the world’s most expensive healthcare
system, it continues to underperform relative to other
countries on most dimensions measured. Among the
11 nations studied in the report (up from 7 in previous
versions), the United States ranks last overall, as it
did in the 2004, 2006, 2007, and 2010 editions. The
report says the United States fails to achieve better
health outcomes than several of the other counties
and is last or near last on dimensions of access, efﬁ-
ciency, and equity. The report incorporates patient
and physician survey results on care experiences and
ratings on various dimensions of care.
The most notable way the United States differs
from other industrialized nations, according to the
report, is the absence of universal health insurance.
The report notes that the ACA is increasing the
number of Americans with coverage and improving
access to care. Much of the data in the report are from
years prior to the full implementation of the ACA, and
thus it is not surprising that the United States
underperforms on measures of access and equity
(Figure 28). Major ﬁndings of the 2014 update include:
Quality
Indicators of quality include effective care, safe
care, coordinated care, and patient-centeredcare. The United States fares best on preven-
tive and patient-centered care, while lower
scores on safe care and coordinated care pull
the U.S. quality score down.
Access
Americans are most likely to say they have had
access problems related to cost. Patients in the
United States have rapid access to specialized
health services, but are less likely to report
rapid access to primary care. In some countries,
such as Canada, patients have little to no
ﬁnancial burden, but may experience wait
times for specialized services. The Netherlands,
U.K., and Germany provide universal coverage
with low out-of-pocket costs, while maintain-
ing quick access to specialized services.
Efﬁciency
The United States ranks last in efﬁciency, with
poor performance on measures of national
health expenditures and administrative costs
as well as on measures of administrative has-
sles, avoidable emergency room use, and
duplicative medical testing.
Equity
The United States ranks a clear last on mea-
sures of equity. Americans with below-average
incomes were much more likely to report not
visiting a physician when they are sick; not
getting a recommended test, treatment, or
follow-up care; or not ﬁlling a prescription or
skipping doses because of cost (66).
MANY DRIVERS OF INCREASED SPENDING. There
are many forces driving healthcare spending. An
annual series of Commonwealth Fund-sponsored
analyses of Organization for Economic Cooperation
and Development (OECD) health data dating back to
1999 has explored a number of potential factors,
including: administrative complexity, the aging of the
population, the practice of “defensive medicine”
under threat of malpractice litigation, the burden of
chronic disease, healthcare supply and utilization
rates, resource allocation, and the use of technologi-
cally advanced equipment and procedures. These and
other studies have found, contrary to often-cited ex-
planations, the United States has a relatively young
population, average or below average rates of chronic
conditions, and comparatively few doctor visits and
hospitalizations compared with other industrialized
countries. Instead, these studies suggest major rea-
sons for higher spending in the United States include
substantially higher prices and more fragmented care
delivery, a higher percentage of specialists, higher
FIGURE 28 2013 Overall Healthcare Ranking of Industrialized Countries
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This ﬁgure details the Commonwealth Fund overall healthcare ranking of industrialized countries as of 2013. Countries included are Australia (AUS),
Canada (CAN), France (FRA), Germany (GER), Netherlands (NETH), New Zealand (NZ), Norway (NOR), Sweden (SWE), Switzerland (SWIZ),
United Kingdom (UK) and the United States (US). Countries are ranked by quality care (effective care, safe care, coordinated care, patient-centered care),
access (cost-related care, timeliness of care), efﬁciency, equality, healthy lives, and health expenditures per capita in 2011. Country rankings in the
top 2 for each category are shaded dark blue, the middle for each category shaded medium blue, and the bottom 2 for each category in light blue.
*Includes ties. **Expenditures are shown in U.S. purchasing power parity; Australian $ data are from 2010. Source: The Commonwealth Fund.
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D32hospital spending per discharge, and the highest
levels of drug utilization, prices, and spending (67)
(Figure 29).
JAMA ARTICLE OUTLINES ANATOMY OF U.S. HEALTHCARE.
A study titled “The Anatomy of Health Care in the
United States, published in JAMA, uses publicly
available healthcare data from 1980 to 2011 to build a
U.S. healthcare trend proﬁle. The study shows 2011
spending on healthcare topping $2.7 trillion, doubling
since 1980 as a percentage of the U.S. GDP at almost
18%. In the same year, U.S. healthcare employed
15.7% of the workforce.
Although the average life expectancy of U.S. citi-
zens has lengthened by 30 years since 1900, averaging
81 years for women and 76 years for men, the study
authors said the rise of healthcare expenditures has
little to do with the aging population. Between 2000
and 2011, increase in price (particularly of drugs,
medical devices, and hospital care) as opposed to
increased demand for services or demographic change
produced most of the increase in the healthcaresector’s share of GDP, according to the study’s
authors. In addition, the study found personal out-of-
pocket spending on healthcare actually fell by one-
half, from 23% in 1980 to 11% in 2011. The study says
chronic illness accounts for 84% of the costs overall.
Study authors point out 3 factors that have caused
the most change in the period studied:
1. Consolidation—with fewer general hospitals and
more single-specialty hospitals and physician
groups, producing ﬁnancial concentration in larger
healthcare systems, insurers, pharmacies, and
beneﬁt managers;
2. Information technology—in which investment has
been made, but with value proving elusive and
mass-scale resulting in better coordination of care
not yet produced; and
3. Patients as consumers—with patients seeking new
sources of information and demanding more
accountability and transparency, and patient
satisfaction being tied to ﬁnancial metrics for many
organizations (68).
FIGURE 29 Healthcare Spending as a Percentage of GDP for OECD Countries
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This ﬁgure shows healthcare spending as a percentage of GDP for OECD countries from
1980 through 2011. The United States is shown in red. France is shown in green. Germany
is shown in gold. Switzerland is shown in purple. Canada is shown in orange. Japan
is shown inmedium blue. The U.K. is shown in grey. Sweden is shown in teal. Italy is shown
in dark blue, and Australia is shown in light blue. The OECD average in 2011 is 9.3% of
GDP. GDP ¼ gross domestic product; OECD ¼ Organization for Economic Cooperation and
Development. Source: OECD Health Data, produced by Veronique de Rugy, Mercatus
Center at George Mason University.
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D33HEALTHCARE SPENDING EXPECTED TO INCREASE
AFTER 5-YEAR SLOWDOWN. Estimates from the
Ofﬁce of the Actuary at CMS, in a study published in
Heath Affairs, predicts that U.S. healthcare spending
will increase faster in the next decade than it did
during the Great Recession. Healthcare spending
increased by 3.6% in 2013, by 5.6% in 2014, and is
projected to increase by 6% a year from 2015 to 2023.
The increased rate of growth is based on the
continued implementation of the ACA coverage ex-
pansions, faster projected economic growth, and the
aging of the population. This rate of increase, how-
ever, is lower than during the period from 1990 to
2008 when the average annual growth rate was 7.2%.
The healthcare share of GDP is expected to rise to
nearly one-ﬁfth of the nation’s economy by 2023.
Economists on the study attributed the recent
slowdown to a number of factors, including the
sluggish economy during the recession as individuals
and state and local governments curbed their
spending on healthcare, slower growth per person in
Medicare, increases in cost sharing for the privately
insured, changes in medical practice, and a shift from
high-priced prescription drugs to less costly generics.
Speciﬁcally for Medicare, study projections show
that from 2016 to 2023, an increase in enrollees and
the likelihood they will use more services as they age
will cause Medicare spending to grow by an average
of 7.3% per year, which is still 2.2 percentage points
lower than in 2008. By 2023, health expenditures
ﬁnanced by federal, state, and local governments are
projected to account for 48% of national health
spending, up from 44% in 2012 (69). Figures 30 and 31
give additional detail from the CMS national health
expenditure projections, including distribution of
spending and average annual growth by type of ser-
vice and type of payer.
ACA TOTAL PROJECTED COSTS LOWER. The CBO
announced in March 2015 that the ACA would cost
$142 billion, or 11% less than the most recent earlier
projection because health insurance premiums are
rising more slowly, thus requiring less of a govern-
ment subsidy. Projections of the cost of the law have
been falling for several years, and now analysts are
beginning to assess the law’s impact from its ﬁrst full
year of implementation (70).
MEDICAID EXPANSION SPREADING BUT COSTS
MORE PER PERSON THAN EXPECTED. As of July 16,
2015, 31 states including the District of Columbia have
adopted the expansion of their Medicaid programs
under the ACA and 19 states are not currently adopting
the expansion (71) (Figure 32). The CMS Ofﬁce of the
Actuary reported that Medicaid costs per person were
signiﬁcantly higher than expected (approximately$1,000 per person higher) due to the newly covered
individuals’ pent up need for health services (72).
INFORMATION TECHNOLOGY
REPORT TO CONGRESS DETAILS EHR ADOPTION
PROCESS. In October of 2014, the Ofﬁce of theNational
Coordinator for Health Information Technology (ONC)
in its annual Report to Congress outlined the rapid
growth of EHR technology since the passage of the
Health Information Technology for Economic and
Clinical Health (HITECH) Act in 2009. According to the
report, the health information technology infrastruc-
ture has grown rapidly and become more ﬂexible and
resilient, but much progress remains to be made,
particularly in health information interoperability and
the “sharing of patient information electronically across
organizational, vendor and geographic boundaries.”
According to the report, in 2013, 59% of hospitals
and 48% of physicians have a basic (meeting
minimum standards related to clinical information
order entry and results management) EHR system,
recording respective increases of 47 percentage
points and 26 percentage points since 2009. There
also is widespread participation among eligible hos-
pitals and professionals in the CMS EHR incentive
programs.
The report says despite progress in establishing
standards and services to support the Health
FIGURE 30 Projected National Health Expenditure Distribution and Average Annual Growth by Type of Service, 2012 to 2023
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This ﬁgure depicts the projected national health expenditure distribution and average annual growth by type of service from 2012 to 2023.
Distribution of spending for categories of hospital care, physician and clinical services, prescription drugs, all other, and non-PHC expenses are
shown from greatest percentages (lightest blue) to least percentages (darkest blue). Annual growth in spending is shown for hospital,
physician, and prescription drug categories for 2013 (lightest blue), 2014 (medium blue), 2015 (darker blue), and 2016 to 2023 (darkest blue).
Note: Sum of pieces may not equal 100% due to rounding. All Other PHC includes spending for the categories of: Dental, Other Professional,
Nursing Home, Home Health, Durables, Other Nondurables, and Other Personal Health Care. The Non-PHC categories are: Government
Administration, Net Cost of Private Health Insurance, Government Public Health, Research, Structures, and Equipment. non-PHC ¼ nonpersonal
healthcare; PHC ¼ personal healthcare. Source: Centers for Medicare and Medicaid Services.
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D34Information Exchange (HIE), there is not yet sufﬁcient
standardization to allow seamless interoperability
because it is “still inconsistently expressed through
technical and medical vocabulary, structure andFIGURE 31 Projected National Health Expenditure Distribution and
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ONC OUTLINES DRIVERS OF EHR ADOPTION.
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FIGURE 33 Adoption of EHRs Among Ofﬁce-Based Physicians
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This ﬁgure shows the adoption of EHRs as a percentage of ofﬁce-based physicians from
2001 through 2013. Adoption is in groups of any EHR system (blue) and a basic system
(orange). EHR ¼ electronic health record. Source: CDC/NCHS 2013 National Ambulatory
Medical Care Survey.
FIGURE 32 Current Status of State Medicaid Expansion Decisions
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Map of the United States shows the current status of state Medicaid expansion decisions as of July 16, 2015. States that have adopted
expansion of Medicaid are shown in blue, and states that have not adopted Medicaid expansion are shown in orange. **MT has passed
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Coverage under the PA waiver went into effect January 1, 2015, but it is transitioning coverage to a state plan amendment. WI covers adults up
to 100% federal poverty level in Medicaid, but did not adopt the Affordable Care Act expansion. Source: The Kaiser Family Foundation.
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D35the use of ﬁnancial incentives, the availability of
technical assistance, board certiﬁcation require-
ments, and the ability to exchange patient informa-
tion with other providers were among the top drivers
of EHR adoption. Data from the 2013 National
Ambulatory Medical Care Survey showed that 80% of
physicians said they were already using an EHR or
were planning to implement the technology. Some
62% of physicians who adopted health IT tools iden-
tiﬁed ﬁnancial incentives and penalties as a major
inﬂuence on their decisions to adopt, compared with
only 23% of physicians who adopted before 2009. Of
the EHR adopters, 82% were using a meaningful
use-enabled EHR. For those who did not plan to
adopt an EHR, lack of time and other resources was
most often cited as the reason (Figures 34 and 35).
According to the data, with an EHR adoption rate of
77%, primary care physicians outpaced physicians in
medical specialties (68%) and surgical specialties
(63%). Practice size made a difference in adoption
rates, with approximately 92% of physician practices
with >11 physicians adopting EHRs, compared with
67% of practices with 2 or 3 physicians and just 47% of
solo physicians (74).
EHR ADOPTION HIGH, BUT BARRIERS TO HEALTH
INFORMATION EXCHANGE EXIST. Despite rapid
adoption of EHR systems, the ONC in its report to
Congress said that electronic health information is
not sufﬁciently standardized to allow seamless
operability, limiting the ability of healthcare pro-
fessionals to share patient health information acrossorganizational, vendor, and geographical boundaries
(72). Frustration at the slow progress of EHRs was
also brought out at a recent Senate hearing to ﬁnd
legislative improvements to assist EHR adoption.
Witnesses at the hearing put some of the blame on
the vendor community, citing reports of vendors
FIGURE 34 Physician Adoption Status in 2013
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This ﬁgure shows percentages related to physician adoption of EHRs in 2013.
Categories include adopted, MU EHR (59% blue); adopted, other (12%
purple); planning to adopt (10% teal); uncertain on adoption (11% red);
retiring, not adopting (3% grey); and not adopting, other reason (5% orange).
EHR ¼ electronic health record; MU ¼ meaningful use. Source: CDC/NCHS
2013 National Ambulatory Physician Workﬂow Survey.
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D36establishing proprietary standards that effectively
turn their medical records into walled gardens,
undermining interoperability by design. Senators
suggested that the industry needs some measure of
harmonization to ensure that privacy and security
features hold from one system to the next (75).
The American Hospital Association has formed the
Interoperability Advisory Group (IAG) and has issued
a report, “Achieving Interoperability That Supports
Care Transformation,” which identiﬁes and addresses
barriers to interoperability in 3 major categories:
insufﬁcient infrastructure, technology challenges,
and unresolved policy issues. The American Hospital
Association’s report recommends that health systems
identify priorities and make these priorities clear to
vendors. The report also urges the federal govern-
ment to emphasize standards, certiﬁcation, and
testing and discourages state governments from
establishing unique requirements (76).
CARDIOLOGY STUDY SHOWS SIGNIFICANT ADOPTION
BUT ROOM FOR IMPROVEMENT. An August 2014 ACC
study of beneﬁts and challenges associated with
information technology says nearly 8 of 10 (78%) car-
diologists indicated they have been using EHRs for 2
years or more, and 9 of 10 survey respondents saidthey have a fully functioning EHR program or are in
the process of implementing one. In addition, nearly
80% of respondents said they are participating in the
EHR incentive program, up from 58% in 2011.
Nearly all of the respondents said their EHRs
allowed for patient/clinical notes (95%), ordering of
prescriptions (93%), and electronic tracking of patient
medications (92%). In addition, 76% of those surveyed
said their EHRs are capable of importing lab results,
and 50% report EHRs capable of reporting imaging
results. Respondents said their EHRs had the greatest
impact on timely access to medical records and pre-
scription reﬁlls, helping to avoid medical errors, and
assisting in communication with other providers.
However, only approximately one-third of cardiolo-
gists indicated they were extremely/very satisﬁed
with their EHR systems overall, most often citing lack
of interoperability with other software and lack of
integration with medical devices as sources of dissat-
isfaction (77).
BEYOND STAGE 1: FRUSTRATION GROWS OVER MU
PROGRAM. The American Recovery and Reinvest-
ment Act of 2009 authorized the CMS to provide
ﬁnancial incentives to providers and hospitals for
adopting MU of certiﬁed EHR technology. Under this
authority, the ONC set standards, implementation
speciﬁcations, and certiﬁcation criteria for electronic
medical record technology. MU is a 3-stage compli-
ance program that requires providers to show that
they use EHRs in measurable ways. To receive
ﬁnancial incentives (and, over time, to avoid ﬁnancial
disincentives), physicians and hospitals must attest
to reaching different stages of MU (78). Stage 1 was
designed to drive adoption of EHR and has achieved
substantial success. Stages 2 (advanced clinical pro-
cesses) and 3 (improved outcomes) are proving to be
more difﬁcult.
Although a majority of physicians have imple-
mented EHRs, the AMA says most are not getting
what they expected from the technology, and the
organization is encouraging clinicians to share their
perspectives on EHRs and the MU program. The AMA
in late 2014 released a framework to prioritize EHR
usability woes. The organization said its members are
complaining about ill-conceived EHR workﬂows,
time-consuming data entry, interference with face-
to-face patient care, and overwhelming fatigue with
electronic messages and alerts. The AMA says a
“one-size-ﬁts-all” approach “diminishes the ability of
the technology to perform the most critical function—
helping physicians care for their patients” (79).
The adoption of Stage 2 of the MU program has
been lackluster—as of mid-2015, only approximately
one-quarter of eligible physicians and less than
FIGURE 35 Major Inﬂuences on Decision to Adopt an EHR
4%
6%
16%
27%
15%
7%
23%
13%
17%
35%
36%
37%
39%
62%
0% 10% 20% 30% 40% 50% 60% 70%
Availability of certified EHRs
Assistance with selecting EHR
Technical assistance with EHR implementation
Electronic exchange capability
Trusted colleagues using EHRs
Board certification requirement
Incentive payments or financial penalties
Adopted 2010–2013 Adopted 2009 or earlier
This ﬁgure shows in decreasing percentage the major inﬂuences on the decision to adopt an EHR. Percentage lines are divided into adopted
2010 to 2013 (blue) and adopted 2009 or earlier (orange). EHR ¼ electronic health record. Source: CDC/NCHS 2013 National Ambulatory
Physician Workﬂow Survey.
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D37one-half of hospitals had participated. Disagreements
over MU may only escalate in 2015, with eligible
professionals seeing a 1% decrease in Medicare re-
imbursements for each year they do not meet MU
requirements. That penalty will rise by 1 percentage
point each year to a maximum of 5%. Responding to
concerns in April 2015, CMS proposed easing of Stage
2 regulations, eliminating approximately 12 measures
that were considered redundant and providing more
ﬂexibility in MU reporting (80).
In March of 2015, CMS issued proposed rules for
Stage 3, which is scheduled to go into effect in 2017.
This ﬁnal stage requires providers to send electronic
summaries for 50% of patients they refer to other
providers, receive summaries for 40% of patients
referred to them, and reconcile past patient data with
current reports for 80% of such patients. The AMA
and the Medical Group Management Association
(MGMA) have sought a delay in Stage 3 rules, and
Lamar Alexander (R-Tenn.), chairman of the Senate
Health, Education, Labor and Pensions Committee,said his committee would also push to delay imple-
mentation of Stage 3 rules (81).
ACC ACTIVE IN EHR ADOPTION PROCESS. The ACC,
a long-time supporter of EHR adoption as a driver of
improved patient care quality, has been active in
helping members move through the information
technology adoption process. The College’s Infor-
matics and Health Information Technology Task
Force addresses data interoperability, promotes EHR
adoption, coordinates EHR vendor engagement, and
develops tools and strategies to improve the effec-
tiveness of ACC registries (82). The ACC regularly
submits comments to CMS on the ever-evolving MU
program, urging shorter reporting periods, more
ﬂexibility for incentive program participants, and less
constricting requirements on some portions of the
program (83). Interoperability remains a signiﬁcant
concern to the ACC, and in July of 2015, ACC Task
Force member Michael J. Mirro, MD, testiﬁed about
information blocking before a hearing of the
Senate Health, Education, Labor and Pensions (HELP)
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D38Committee. Mirro said in his testimony that “many
EHR vendors provide the functionality needed by the
healthcare community, but also require the purchase
of the speciﬁc company’s health IT products to make
the elements of the EHRs fully interoperable.” Mirro
added, “In emergency situations, the rapid secure
exchange of health information is critical. We must
work toward rewarding interoperability and discour-
aging information blocking” (84).
REPORT HIGHLIGHTS STATE EXPERIENCES IN
ESTABLISHING HIEs. In 2009, the ONC created the
State HIE Program, offering states and territories $564
million in funding and providing guidance for states to
enable secure electronic information exchange. To
understand the effects of this program on HIE prog-
ress, the ONC contracted with the University of Chi-
cago to conduct a multi-year evaluation. The
evaluation report, issued in late 2014 highlights an in-
depth assessment of 6 representative states (Iowa,
Mississippi, New Hampshire, Utah, Vermont, and
Wyoming) regarding their experiences establishing
HIEs at the state level. One key ﬁnding was the
importance of ACOs. In those stateswhere therewas an
increase in ACOs, HIEs were found to be fundamental.
This was the case in Vermont and Iowa, which had
made more progress than some of the other states
in the report. Successful states found that marketing
their services to ACOs, or requiring ACO participat-
ion in state-led services, bolstered demand and
participation. Another key factor was stakeholder
engagement. States that were able to get large health
systems on board early in the process made more
progress than those that did not. Participation also
increased in response to ﬁnancial incentives at the
state and federal level (such as MU) as well as to state-
level requirements for participation. In a few states,
legislative action was needed to address privacy
concerns (85).
NO MORE DELAYS ON ICD-10 TRANSITION. After 3
signiﬁcant delays, the controversial transformation to
ICD-10, the WHO’s medical classiﬁcation system,
began in October 2015. Some are saying the transition
could be incredibly detrimental to small physician
practices and others believe implementation is over-
due because it may help healthcare providers better
respond to health threats such as Ebola, better monitor
the severity of diseases, and improve patient safety.
ICD-10, used for diagnosis and procedure reporting,
has been delayed 3 times—in 2009, 2012, and 2014—due
in large part to vocal opposition from the AMA. For
years, the AMA has been saying that the ICD-10
switchover “will create signiﬁcant burdens on the
practice of medicine with no direct beneﬁt toindividual patients’ care.” The estimated cost of ICD-
10 implementation for small physician practices is
approximately $8,167 but can reach tens of thousands
of dollars, according to the Professional Association of
Health Care Ofﬁce Management. Previous estimates in
2014 had been signiﬁcantly higher, but new educa-
tional and training materials now available should
help providers lower implementation costs (86).
In response to AMA concerns in July of 2015, CMS
and AMA announced efforts to continue to help
physicians prepare for ICD-10 implementation. These
revisions to ICD-10 policy include:
 For a 1-year period starting October 1, 2015, Medi-
care claims will not be denied solely on the speci-
ﬁcity of the ICD-10 diagnosis codes provided, as
long as the physician submitted an ICD-10 code
from an appropriate family of codes. In addition,
Medicare claims will not be audited based on the
speciﬁcity of the diagnosis codes as long as they
are from the appropriate family of codes. Medicare
Administrative Contractors and Recovery Audit
Contractors will follow this policy.
 To avoid potential problems with midyear coding
changes in CMS’s quality programs (PQRS, VBM,
and MU) for the 2015 reporting year, physicians
using the appropriate family of diagnosis codes
will not be penalized if CMS has difﬁculties
in accurately calculating quality scores (i.e., for
PQRS, VBM, or MU). CMS will continue to monitor
implementation and adjust the duration if needed.
 CMS will establish an ICD-10 ombudsman to help
receive and triage physician and provider problems
that need to be resolved during the transition.
 CMS will authorize advanced payments if Medicare
contractors are unable to process claims within
established time limits due to problems with ICD-
10 implementation (87).
TECHNOLOGY EXPERTISE NEEDED FOR ACO
GROWTH. The estimated number of Americans
covered by ACOs increased more than 30%, and pro-
vider organizations face technological challenges as
they try to expand these value-based delivery
models, according to Modern Healthcare’s annual list
of ACOs by state. While some ACOs have EHRs that
communicate well with each other and can track
where care is delivered, others have dozens of EHRs
among their participating groups that often are not
interoperable. According to David Muhlestein with
Levitt Partners Center for Accountable Care Intelli-
gence, ACO healthcare platforms should have func-
tions for population health management as well as
staff trained in how to use these tools to coordinate
care and keep patients healthy (88).
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2015. International Data Corporation (IDC), a global
technology provider of market intelligence, re-
cently released its IDC Health Insights annual list
of health information technology predictions. This
list of predictions for the period 2015 to 2020
includes:
 With healthcare costs rising, operational in-
efﬁciency will become critical at 25% of hospitals,
resulting in the development of a data-driven digi-
tal hospital strategy that requires budget in 2016.
 By 2015, 50% of healthcare organizations will have
experienced 1 to 5 cyberattacks in the previous 12
months with 1 of 3 attacks deemed successful,
requiring healthcare organizations to invest in a
multi-prong security strategy to avoid disruptions
to normal operations and incurring ﬁnes and
notiﬁcation costs.
 Driven by the increased pressure to improve quality
and manage costs, 15% of hospitals will create a
comprehensive patient proﬁle by 2016 that will
allow them to deliver personalized treatment plans.
 By 2020, 80% of healthcare data will pass through
the cloud at some point in its lifetime, as providers
seek to leverage cloud-based technologies and
infrastructure for data collection, aggregation, an-
alytics, and decision making.
 To control spiraling healthcare costs related to
managing patients with chronic conditions, 70% of
healthcare organizations worldwide will invest in
consumer-facing mobile applications, wearable
technology, remote health monitoring, and virtual
care by 2018, which will create more demand for
big data and analytics capability to support popu-
lation health management initiatives.
 As a result of increased pressures to deliver
better outcomes of care more efﬁciently, payers
will implement newer reimbursement models for
35% of their payments to providers in North
America and the European Union within the next 36
months, resulting in related investments in quality
measurement, payment, and billing systems.
 By 2020, 42% of all healthcare data created in the
digital universe will be unprotected but needs to be
protected, as use of data and analytics continues to
proliferate and more stakeholders are involved in
delivery of care (89).
CHANGES IN CLINICAL RISK ASSESSMENT
AND MANAGEMENT OF LIPID ABNORMALITIES
ACC/AHA RELEASE PREVENTION AND CHOLESTEROL
MANAGEMENT GUIDELINES. On November 12, 2013, theACC and the AHA jointly released both the Guideline
on the Assessment of Cardiovascular Risk and the
Guideline on the Treatment of Blood Cholesterol as
well as a CV risk calculator as a companion to the new
guidelines. The risk calculator can be accessed
at http://tools.acc.org/ASCVD-Risk-Estimator/. These
clinical documents introduced broader assessment
and prevention strategies, made signiﬁcant changes in
recommendations for cholesterol management, laid
the groundwork for possible future value-based pay-
ment strategies, and stirred controversy among clini-
cians and in the general public.
The new Guideline on the assessment of risk was
broadened to include assessment of risk for stroke as
well as heart attack, and it provided new gender- and
ethnicity-speciﬁc formulas for predicting risk in
African American and white women and men. An
online risk calculator, which requires input of age,
sex, information about smoking, total and high-
density lipoprotein cholesterol levels, and systolic
blood pressure, is designed to enable clinicians to
generate 10-year risk estimates for speciﬁc patients.
The Guideline also provided additional methods of
determining a patient’s lifetime risk and weighed in
on the usefulness of newer markers of risk (condi-
tions that can be measured in urine, in blood, or by
computed tomography). The Guideline did not sup-
port using these new risk measures routinely in risk
management, but 4 markers showed promise if used
after quantitative risk assessment to help inform
treatment decisions. These markers include family
history of premature CVD, coronary artery calcium
score, high sensitivity C-reactive protein levels, and
ankle brachial index (90).
The new Guideline on the treatment of cholesterol
established new protocols for lowering blood cho-
lesterol to help diminish cardiovascular risk in
adults. The guideline no longer recommended treat-
ing to traditional LDL cholesterol targets, instead
saying that clinicians should focus on assessing
patients’ risk of atherosclerotic cardiovascular di-
sease (ASCVD) events and whether they fall into 1 of
4 high-risk patient groups, for which moderate- or
high-intensity statin therapy is recommended. These
groups include:
 Patients with clinical ASCVD
 Patients with LDL cholesterol levels $190 mg/dl
 Older diabetic patients (age range, 40 to 75 years)
with LDL cholesterol levels of 70 to 189 mg/dl and
without clinical ASCVD
 Patients without clinical ASCVD or diabetes but
with LDL cholesterol levels of 70 to 189 mg/dl and
estimated 10-year ASCVD risk $7.5%
Laslett et al. J A C C V O L . 6 6 , N O . 1 9 , S U P P L D , 2 0 1 5
2015 ACC Environmental Scanning Report N O V E M B E R 1 0 , 2 0 1 5 : D 1 – 4 4
D40With few exceptions, the use of lipid-modifying
drugs other than statins was discouraged and life-
style modiﬁcations were recommended. Guideline
authors acknowledged that some patients would not
tolerate high-dose statins and that patient prefer-
ences should be discussed, particularly in primary
prevention (91).
BREAKWITH TRADITIONAL CHOLESTEROLMANAGEMENT
STRATEGIES GENERATES CONTROVERSY. Taken toge-
ther, these new guidelines represented a major de-
parture from previous approaches and generated
signiﬁcant controversy in both the clinical and lay
press. Harvard Medical School researchers Paul M.
Ridker and Nancy R. Cook reported their ﬁndings that
the online calculator greatly overstated a patient’s
risk of developing a heart problem and that the new
guidelines would lead millions of additional people to
take statins, exposing them to side effects with little
potential gain (92). A study published in the New
England Journal of Medicine estimated that 56 million
American adults, or almost one-half those age 40 to
75 years, would be advised to take statins under the
new guideline, compared with 43.2 million or 37.5%
under the older guidelines (93). A The New York Times
article gave voice to critics who said the drafting
committee, in a departure from previous practice,
relied solely on randomized-controlled clinical trials,
ignoring other valuable data. The article included
others who were critical of the sudden release of
guidelines that would so greatly change existing
practice (94).
TWO STUDIES IN 2015 LEND SUPPORT TO THE NEW
GUIDELINES. In July of 2015, 2 separate studies were
published that may lend support to the new guide-
lines: one suggesting that these guidelines are better
at identifying who is truly at risk of a heart attack, and
the other suggesting that treating more people with
statins would be cost effective, even with a signiﬁcant
increase in use.
The ﬁrst study, published in JAMA and funded by
the NIH, looked at 2,400 individuals who partici-
pated in the Framingham Heart study and did
not take statins to determine which of these par-
ticipants would have been eligible for statins under
the new guidelines versus who would be eligible
under the older guidelines. As expected, more
people were eligible under the new guidelines (39%)
than under the old (14%). Then they looked at
how often individuals in each group experienced a
heart attack or stroke, or died from cardiovascular
causes. The rate between the 2 groups was roughly
equal (6.9% vs. 6.3%), suggesting that the newguidelines did not result in treatment of many more
people who did not need statins. In addition, only
1% of participants deemed ineligible for statins un-
der the new guidelines had a heart attack or stroke
over 9 years, compared with 2.4% of those ineligible
under the older guidelines, suggesting that the new
guidelines may do a better job of identifying
individuals who need statins and those who do
not (95).
The second JAMA study from researchers at Har-
vard’s T.H. Chan School of Public Health found that
treating patients who have a 7.5% risk of heart attack
or stroke over the next decade was cost-effective,
even though more people would be treated. They
calculated that every QALY gained cost $37,000, a
number considered acceptable. Even more lenient
thresholds of 4% risk ($100,000 QALY) and 3% risk
($150,000 QALY) would prove cost-effective because
of a projection of 125,000 to 160,000 fewer heart at-
tacks and strokes each decade. An editorial accom-
panying the 2 studies said, “Available evidence
indicates that statins are both effective and cost-
effective for primary prevention, even among
low-risk individuals” (96). The QALY is a generic
measure of disease burden including both the quality
and the quantity of life lived. An intervention with a
lower cost to QALY, saved incremental cost effec-
tiveness ratio (ICER) is preferred over an intervention
with a higher ICER. In the United States, the accept-
able value of a QALY is often set at $50,000 to
$100,000 or higher (97).
RISK CALCULATOR FORMS BASIS FOR CMS RISK
REDUCTION VALUE-BASED PAYMENT MODEL. In
May of 2015, CMS announced a request for applica-
tions for the Million Hearts CVD Risk Reduction
Model randomized-controlled trial to target in-
centives for providers to engage in individual CVD
risk calculation and population-level risk manage-
ment. Instead of focusing on the individual compo-
nents of risk, participating practices will use the ACC/
AHA Risk Calculator to engage in risk stratiﬁcation
across a patient panel to identify those at highest risk
for ASCVD.
The model is designed to identify successful pre-
vention and population health interventions for CVD
implemented within the following framework:
 Universal risk stratiﬁcation of all Medicare-eligible
beneﬁciaries who meet the inclusion criteria using
the ACC/AHA ASCVD Pooled Cohort 10-year Risk
Calculator.
 Evidenced-based risk modiﬁcation using shared
decision making between beneﬁciaries and care
teams in order to reduce ASCVD risk scores.
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ment strategies based on needs identiﬁed during
risk stratiﬁcation of beneﬁciaries.
 Reporting of continuous risk calculator variables,
ASCVD 10-year risk score, and a cardiovascular
PQRS measure set through a data registry provided
as part of the model test. As an added beneﬁt,
participating practices will also have the option of
reporting on additional PQRS measures to meet
both the PQRS and VM reporting requirements (98).
FDA APPROVES FIRST IN NEW CLASS OF COSTLY
CHOLESTEROL-LOWERING DRUGS. In July 2015, the
FDA approved the ﬁrst of a new class of drug that can
sharply lower cholesterol levels: the PCSK9 (propro-
tein convertase subtilisin/kextin 9) enzyme in-
hibitors. The approved drug is alirocumab (brand
name, Praluent), developed by Sanoﬁ and Regeneron
Pharmaceuticals. A second drug in the class, evolu-
cumab (brand name, Repatha), which was developed
by Amgen, was approved in August 2015.
The medication is injected, generally once or twice
a month, and evidence from randomized-controlled
trials suggests it is well tolerated and highly effective
in reducing LDL cholesterol. The efﬁcacy and safety
of Praluent were evaluated in 5 placebo-controlled
trials, involving 2,476 participants exposed to Pralu-
ent. All participants were at high risk for heart attack
or stroke, and were taking maximally tolerated doses
of a statin, with or without other lipid-modifying
therapies. Participants taking Praluent had an
average reduction in LDL cholesterol ranging from
36% to 59%, compared with placebo. The FDA
approval for alirocumab is for patients who have had
heart attacks, strokes, chest pain, or related condi-
tions, or have a genetic condition that causes high
cholesterol and who require additional lowering of
LDL despite taking the highest dose of a statin that
they can tolerate (99).
Regulators in Europe, where evolucumab recently
was approved and alirocumab was recommended for
approval, would allow broader use by people who
have high risk but have not yet had a heart attack or
stroke. Studies aimed at showing that the drugs pre-
vent heart attacks and strokes are under way, but
results are not expected until approximately 2018.
However, results from current trials do suggest mor-
tality beneﬁts (100).
The approval of this new class of medications
rekindled an ongoing concern about the high cost of
so-called specialty medications. The list price for
alirocumab is $560 per injection, equivalent to $40
per day or $14,600 per year. While these drugs areconsidered highly effective at signiﬁcantly lowering
blood cholesterol, the high cost and the fact that they
will be prescribed for maintenance therapy for one of
the world’s most prevalent medical conditions is
generating major concern among health plans and
pharmacy beneﬁt managers (101,102).
CVS URGES REWRITE OF CHOLESTEROL TREATMENT
GUIDELINES. In August 2015, CVS Health, the nation’s
second largest pharmacy beneﬁt manager, called on
the ACC and the AHA to revamp the new cholesterol
treatment guidelines to provide more clarity on the
use of the new, more expensive PCSK9 medications. A
letter from the company, published in JAMA, urged
the medical professional societies to return to speciﬁc
target levels for LDL cholesterol. The unusual move
from CVS is the latest example of an escalating
concern over ever-rising pharmaceutical prices, with
insurers using aggressive tactics to obtain steep price
discounts from pharmaceutical companies and tightly
controlling patient access to the most expensive
medications. CVS had indicated earlier that the com-
pany would demand evidence through blood tests if a
patient wanted the new medications and claimed to
be unable to tolerate statins because of side effects
(103).
EZETIMIBE ADDED TO STATIN THERAPY AFTER
ACUTE CORONARY SYNDROME SHOWS IMPROVEMENT.
A study published in the June 18, 2015 edition of
New England Journal of Medicine suggests that the
addition of ezetimibe to statin therapy after acute
coronary syndrome resulted in incremental lowering
of LDL cholesterol levels and improved cardiovascu-
lar outcomes. The double-blind randomized trial
involved 18,144 patients who had been hospitalized
for an acute coronary syndrome within the preceding
10 days and had LDL cholesterol levels of 50 to
100 mg/dl if they were receiving lipid-lowering ther-
apy or 50 to 125 mg/dl if they were not receiving lipid-
lowering therapy. The combination of simvastatin (40
mg) and ezetimibe (10 mg) was compared with sim-
vastatin (40 mg) and placebo. The median time-
weighted average LDL cholesterol level during the
study was 53.7 mg/dl (1.4 mmol/l) in the simvastatin–
ezetimibe group, as compared with 69.5 mg/dl
(1.8 mmol/l) in the simvastatin-monotherapy group
(p < 0.001). The Kaplan-Meier event rate for the pri-
mary end point at 7 years was 32.7% in the simva-
statin–ezetimibe group, as compared with 34.7% in
the simvastatin-monotherapy group (absolute risk
difference, 2.0 percentage points; hazard ratio: 0.936;
95% conﬁdence interval: 0.89 to 0.99; p ¼ 0.016)
(104).
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